Document:

Exhibit
10.3

 

 

September 8, 2014

 

Aqua Metals, Inc.

501 23rd Avenue

Oakland, CA 94606

 

Attention: Dr. Stephen Clarke

 

Re:         Engagement Agreement for Strategic
Consulting Services

 

Dear Dr. Clarke:

 

This letter agreement
(the “Agreement”) confirms the terms and conditions pursuant to which Liquid Patent Consulting. LLC (“Consultant”)
will provide certain strategic, and intellectual property advisory services to Aqua Metals, lnc. (the “Company”)
(the “Engagement”).

 

1.            Services.
Consultant shall assist the Company with all aspects of its business, strategic and intellectual property development, including:

 

(a)          Business
Strategy Activities.

 

		(1)	Identify optimal legal entity structure, shareholding of
parent and structure for all subsidiaries;

 

		(2)	Assess current management and identifying and recruiting
additional key members of the management team and Board of Directors;

 

		(3)	Assess the Company’s market landscape;

 

		(4)	Assess the Company’s current business strategy and
assisting in the formulation of an optimal business strategy, including a development and commercialization strategy;

 

		(5)	Assess the competitive features/functions of the Company’s
current and proposed products and services;

 

		(6)	Assess the Company’s current financial and accounting
processes and recommend revisions to such processes;

 

		(7)	Assess and make recommendations for performance measurement
metrics for various functions/organizations and total enterprise;

 

    	 

    	 

    

 

 

		(8)	Assess and make recommendations for the Company’s
sales compensation structure;

 

		(9)	Assess and make recommendations for the Company’s
customer service methodologies, processes, performance measurement metrics;

 

		(10)	Evaluate and recommend potential strategic partners;

 

		(11)	Assist in development of detailed measurable actionable
business and financial plan for the next 18 months; and

 

		(12)	General corporate advice, as needed and requested.

 

(b)          IP
Related Activities

 

		(1)	Review and analysis of inventions held by the Company to
determine their usefulness, potential for monetization and potential patentability, including advice concerning the increase in
the likelihood or strength of any of the foregoing;

 

		(2)	Interviewing the Company to understand the subject inventions
and researching prior art for purposes of determining the patentability of such inventions;

 

		(3)	Advise and assist in developing a strategy for the preparation
and filing of one or more patents, both United States and foreign, for purposes of adequately protecting the substantive claims
underlying the inventions, including for each for each such invention a complete invention package with technical disclosure documentation
(each, a “Disclosure”) for use in the Company’s patent applications;

 

		(4)	Review and comment on patent applications filed with respect
to such inventions;

 

		(5)	Review and comment on office actions concerning patent
applications and issued patents;

 

		(6)	Advise and assist in developing a strategy for the Company’s
strategic acquisitions of inventions and patent rights to enhance the Company’s portfolio of patent rights, including conducting
the due diligence and acquisition efforts on behalf of the Company;

 

    	2

    	 

    

 

 

		(7)	Advise and assist with regard to licensing, litigation
and sales of patent rights held by the Company; and

 

		(8)	Provide engineering and/or scientific advisory services
to the Company.

 

The IP related services to be provided
by Consultant to the Company set forth in Section 1(b) shall be subject to a written work assignment in the form of Exhibit
A attached hereto (“Work Assignment”).
The Company shall use a Work Assignment to request the IP Services in Section 1(b)(1) through (8). Each Work
Assignment, when signed and delivered by the Company and accepted by Consultant, shall become part of this Agreement and incorporated
herein by this reference. In the event of any conflict between this Agreement and a Work Assignment, this Agreement shall govern
and control.

 

(c)          Additional
Services/Exclusions. It is expressly understood and agreed that Consultant has not provided nor is undertaking to provide any
advice to the Company relating to legal, regulatory, securities, finance, accounting, or tax matters. The services provided to
the Company hereunder are designed to assist, but not replace, the Company’s own intellectual property counsel and other
professional advisers to the Company. Should the Company request Consultant to perform any services or act in any capacity not
specifically addressed in this Agreement, such services or activities shall constitute separate engagements, the terms and conditions
of which will be embodied in separate written agreement(s).

 

2.          Compensation.
As consideration for the services provided under this Agreement, the Company will pay Consultant certain fees as follows:

 

(a)          Cash
Fees. Company shall pay Consultant a cash fee for each of the IP related services in Section 1(b)(1) through (8)
in the amount set forth in the schedule of fees set forth on Exhibit B attached hereto.

 

(b)          Warrants.
Upon execution of this Agreement, the Company shall sell to Consultant or its designees, for the total amount of $1,500, a warrant,
which may be issued in one or more instruments, in the form of Exhibit C attached hereto (the “Warrants”),
to purchase an aggregate of 100 shares of Company common stock (the “Common Stock”), which is in an
amount equal to ten percent (10%) of the total issued and outstanding Common Stock of the Company, on a fully diluted basis, excluding
shares issued or issuable to Wirtz Manufacturing (or any of its affiliates) (“Wirtz”) up to the first $1,000,000 of
investment, as of the date hereof. Such Warrants will be for a term of three (3) years at an exercise price of $0.01 per share
and shall contain cashless exercise and anti-dilution provisions and representations and warranties normal and customary for warrants
issued to investors, and will not be callable or terminable favorable than those granted to any
other person prior to or subsequent to the date of this Agreement. The Company shall bear all costs and expenses of registration,
including the filing and clearing of one or more registration statements. The Warrants may be assigned to any persons or entities
designated by Consultant. For purposes of clarification, the Warrants acquired by the Consultant hereunder are deemed fully paid
and earned as of the date of this Agreement and are not cancellable or reducible for any reason by the Company, expect as provided
in the Warrant itself.

 

    	3

    	 

    
 

 

(c)          Gross
Up of Warrants. In the event that the Company issues any shares of common stock or other securities that are convertible into
shares of common stock, not in connection with a financing, prior to the close of the First Private Placement (as defined below),
to any persons that are its employees (or affiliates or family members of those employees) as of the date of this Agreement, then
the Company will immediately issue a gross up warrant (“Gross Up Warrant”) to Consultant or its designees to purchase
shares of common stock of the Company in an amount equal to 10% of the shares of common stock that are issued or issuable under
the securities issuable to the employees (or affiliates or family members of the those employees. As used herein, the term “First
Private Placement” means the first private placement of the Company’s securities under circumstances that entitle National
Securities Corporation (“NSC”) Cash Fees and Warrants (as such terms are defined in that certain Engagement Agreement
(“NSC Agreement”) between the Company and NSC dated September 8, 2014 with respect to such sale transactions pursuant
to Section 2 of the NSC Agreement.

 

(d)          Patent
Application. In addition, to the services in Section 1(b) and cash fees in subpart (a) of this Section 2, Consultant will
provide, at the Company’s request, turn-key patent application services for the fee of $7,500 per patent application. The
patent legal services will be provided, at the Consultant’s expense, by Dentons US, LLP (“Dentons”) and the
Company will be required to enter fees for a separate engagement with Dentons, although the Company shall only be responsible
for any filing fees or out of pocket expenses incurred by Dentons.

 

(e)          Expenses.
The Company shall fund Consultant’s travel and other reasonable expenses related to the Engagement,
including economy class air fare, business class accommodations, ground transportation, meals and incidentals, in connection with
visits by the Consultant team to the Company’s site, provided that expenses exceeding $1,000 shall be subject to the Company’s
prior approval which shall not be unreasonably withheld.

 

(f)          Payments.
All payments to be made to Consultant hereunder will be made in cash by wire transfer of immediately
available U.S. funds. Except as expressly set forth herein, no fee payable to Consultant hereunder shall be

 

    	4

    	 

    

 

 

(f)          Payments.
All payments to be made to Consultant hereunder will be made in cash by wire transfer of immediately available U.S. funds. Except
as expressly set forth herein, no fee payable to Consultant hereunder shall be credited against any other fee due to Consultant
or any of its affiliates. The obligation to pay any fee or expense set forth herein shall be absolute and unconditional and shall
not be subject to reduction by way of setoff, recoupment or counterclaim.

 

(g)          Compensation
Earned. All the compensation provided under this Agreement will be deemed fully earned as of the date of the Agreement, and
not subject to return in whole or in part or subject to reduction or further limitation, The Company waives any and all rights
of set off against the compensation provided for herein, including any securities underlying any Warrants.

 

(h)          Lock-Up
Period. In the event of an initial public offering by the Company, all Warrants and shares of Common Stock received pursuant
to exercise of such Warrants received by Consultant and its assigns hereunder may not be sold for a period of 12 months following
the initial listing on an exchange.

 

3.          Representations
and Warranties of the Company. The Company warrants and agrees that it is the true and rightful owner of all intellectual property
rights in each of the assets and inventions submitted to Consultant for analysis; that any and all technical invention information
provided to Consultant may, to the actual knowledge of the officers of the Company, be transmitted across country borders subject
to compliance with applicable export control and similar laws; and that no U.S. agency has suspended, revoked, or denied the Company’s
export privileges.

 

4.          Term
and Termination. Consultant’s Engagement will commence upon the execution of this Agreement and shall continue in
effect for a period of one hundred eighty (180) days (the “Initial Term”). After the expiration of
the Initial Term, the Agreement shall automatically renew and continue in effect until it is terminated by either party with
thirty (30) days’ written notice to the other pursuant to Section 10. Upon termination of this Agreement for any
reason, the rights and obligations of the parties hereunder shall terminate, except for the obligations set forth in Sections
2 and 5-18, which shall survive termination.

    	5

    	 

    

 

 

5.          Confidentiality.
Consultant acknowledges that in connection with the Engagement, the Company will provide Consultant with information which the
Company considers to be confidential, including its trade secrets (“Confidential Information”). Consultant
agrees to employ all reasonable efforts to keep the Confidential Information secret and confidential, using no less than the degree
of care employed by Consultant to preserve and safeguard its own confidential information, and shall not disclose or reveal the
Confidential Information to anyone except its employees, consultants, affiliates and contractors who have an obligation
of confidentiality with Consultant. Consultant will not use the Confidential Information except in connection with its performance
of services hereunder, unless disclosure is required by law, court order, or any government, regulatory or self-regulatory agency
or body in the opinion of Consultant’s counsel, in which event Consultant will provide the Company with reasonable advance
notice of such disclosure. “Confidential Information” does not include information which (a)
was in the public domain or readily available to the trade or the public prior to the date of the disclosure; (b) becomes generally
available to the public in any manner or form through no fault of Consultant or its representatives; (c) was in Consultant’s
possession or readily available to Consultant from another source not under obligation of secrecy to the Company prior to the
disclosure; (d) is rightfully received by Consultant from another source on a non-confidential basis; (e) is developed by or for
Consultant without reference to the Company’s Confidential Information; (f) is disclosed by the Company to an unaffiliated
third party free of any obligation of confidence; or (g) is released for disclosure with the Company’s written consent.
Notwithstanding any termination of this Agreement, Consultant’s confidentiality obligations (1) in respect of any material
that qualifies as a “Trade Secret” under the Uniform Trade Secrets Act (“UTSA”)
shall survive in perpetuity under the UTSA until such information ceases to be a Trade Secret, and (2) in respect of any non-Trade
Secret, for a period of two years from the date of disclosure.

 

6.          Indemnification,
The Company hereby agrees to indemnify and hold harmless Consultant and its affiliates and each of their directors, officers,
managers, agents, employees, members and counsel (collectively, the “Consultant Indemnified Parties”)
to the fullest extent permitted by law from and against any and all losses, claims, damages, expenses, or liabilities (or actions
in respect thereof) (“Losses”), joint or several, to which they or any of them may become subject under
any statute or at common law, and to reimburse such Consultant Indemnified Parties for any reasonable legal or other expense (including
but not limited to the cost of any investigation, preparation, response to third party subpoenas) incurred by them in connection
with any litigation or administrative or regulatory action (“Proceeding”), whether pending or threatened,
and whether or not resulting in any liability, insofar as such losses, claims, liabilities, or litigation arise out of or are
based upon the Engagement, including, but not limited to, the Company’s use or misuse (including use contrary to federal
or state law) of the Disclosure(s), the Company’s breach of the representations and warranties contained in Section 3 hereof,
or any violation of U.S. or other import or export controls; provided, however, that while the indemnity provisions herein shall
include any and all claims regardless of whether Consultant’s sole negligence, active or passive, contributed to losses,
they shall not apply to (i) amounts paid in settlement of any such litigation if such settlement is effected without the consent
of the Company, which consent will not be unreasonably withheld, or (ii) Losses arising solely from the willful misconduct,
gross negligence or violation of applicable laws of Consultant Indemnified Parties.

    	6

    	 

    

 

 

The provisions of this
Section 6 shall survive any termination or expiration of this Agreement.

 

7.          Work
Product and Announcements. Consultant’s advice shall be the sole proprietary work product and intellectual property of
Consultant and such advice may not be disclosed, in whole or in part, to third parties other than the Company’s professional
advisors without the prior written permission of Consultant, unless such disclosure is required by law. Any document or information
prepared by Consultant in connection with this Engagement shall not be duplicated by the Company except as explicitly provided
for hereunder or required by law. The Company acknowledges that Consultant, at its option and expense, may place announcements
and advertisements or otherwise publicize the Engagement (which may include the reproduction of the Company’s logo and a
hyperlink to the Company’s website) on Consultant’s website and in such financial and other newspapers and journals
as it may choose.

 

8.          Limitation
of Liability. Consultant shall employ due care and attention in providing the services hereunder. However, the Company acknowledges
that Consultant does not warrant or represent the accuracy or completeness of any public information or any information provided
solely by the Company used in any analysis and that inaccurate or incomplete data may affect the validity and reliability of Consultant’s
work product, including any draft patent Disclosures. Similarly, Consultant makes no representation or warranty with respect to
the non-infringement of any of the assets or inventions described in the Disclosure(s). Consultant makes no warranty, representation,
promise, or undertaking with respect to any legal or financial consequences of, or any other consequences or benefits obtained
from the use of any work product hereunder, including the Disclosure(s), including any representation that any patent(s) will be
granted. The Company assumes all risks related to documentation or technical information and data which may be subject to U.S.
export controls or export or import restrictions in other countries. Consultant SPECIFICALLY DISCLAIMS ANY OTHER WARRANTY, EXPRESS,
IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. CONSULTANT SHALL NOT BE LIABLE
ON ACCOUNT OF ANY ERRORS, OMISSIONS, DELAYS, OR LOSSES UNLESS CAUSED BY ITS GROSS NEGLIGENCE OR WILLFUL MISCONDUCT. TO THE FULLEST
EXTENT PERMITTED BY LAW, NEITHER CONSULTANT NOR ANY OF ITS CONTROLLING PERSONS, AFFILIATES, DIRECTORS, OFFICERS, EMPLOYEES OR CONSULTANTS
WILL BE LIABLE FOR ANY LOSS, DAMAGE OR INJURY (INCLUDING WITHOUT LIMITATION LOST PROFITS, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES)
ALLEGED TO BE CAUSED BY USE OF THE DISCLOSURE(S) OR OTHER SERVICES PROVIDED HEREUNDER. CONSULTANT’S
LIABILITY ARISING UNDER THIS AGREEMENT SHALL BE LIMITED TO THE AMOUNTS PAID BY THE COMPANY TO CONSULTANT WITH REGARD TO THE PROVISION
OF THE SPECIFIC SERVICES THAT GAVE RISE TO THE CLAIM OF LIABILITY, BUT IN NO EVENT WILL SUCH LIABILITY EXCEED THE TOTAL AMOUNT
ACTUALLY PAID TO CONSULTANT PURSUANT TO SECTION 2.

    	7

    	 

    

 

 

Neither the Consultant nor any of its controlling
persons, affiliates, directors, officers, employees or consultants shall have any liability to the Company or any person asserting
claims on behalf of or in right of the Company for any losses, claims, damages, liabilities or expenses arising out of or relating
to the services provided by Dentons on behalf of the Company pursuant to this Agreement, unless it is finally judicially determined
that such losses, claims, damages, liabilities or expenses resulted solely from gross negligence or willful misconduct of the Consultant.

 

9.          Other
Transactions; Disclaimers. The Company acknowledges that Consultant and its affiliates are engaged in other activities from
which conflicting interests or duties, or the appearance thereof, may arise. Information held elsewhere within Consultant but not
accessible will not under any circumstances affect Consultant’s responsibilities to the Company hereunder. The Company further
acknowledges that Consultant and its affiliates have and may continue to relationships with parties other than the Company pursuant
to which Consultant may acquire information of interest to the Company. Consultant shall have no obligation to disclose to the
Company or to use for the Company’s benefit any such non-public information or other information acquired in the course of
engaging in any other transaction (on Consultant’s own account or otherwise) or otherwise carrying on the business of Consultant.

 

The Company further
acknowledges and agrees that Consultant will act solely as an independent contractor hereunder, and that Consultant’s responsibility
to the Company is solely contractual in nature and that Consultant does not owe the Company or any other person or entity, including
but not limited to its shareholders, any fiduciary or similar duty as a result of the Engagement or otherwise.

 

10.         Notice.
All notices, demands, and other communications to given pursuant to this Agreement shall be in writing and shall be personally
delivered, sent by overnight delivery using a nationally recognized courier service, sent by facsimile transmission, or emailed.
Notice shall be deemed received: (a) if personally delivered, upon the date of delivery to the address of the receiving party;
(b) if sent by overnight courier, the date actually received by the recipient; (c) if sent email, when sent. The parties will each
promptly notify the other of any changes to the following contact information.

 

    	8

    	 

    

 

 

	Notices to Consultant shall be sent to:	 	Notices to the Company shall be sent to:
	 	 	 
	Liquid Patent Consulting, LLC:	 	Aqua Metals, Inc.
	12100 Wilshire Blvd, Suite 800	 	501 23rd Avenue
	Los Angeles, CA 90025	 	Oakland, CA 94563
	Attention: Ankur V. Desai	 	Attention: Steve Clarke
	e-mail: adesai@liquidventure.com	 	email: steve.clarke@aqmetals.com

 

11.         Complete
Agreement; Amendments; Assignment. This Agreement sets forth the entire understanding of the parties relating to the subject
matter hereof and supersedes and cancels any prior communications, understandings and agreements, whether oral or written, between
Consultant and the Company. This Agreement may not be amended or modified except in writing. The rights of Consultant hereunder
shall be freely assignable to any affiliate of Consultant, and this Agreement shall apply to, inure to the benefit of and be binding
upon and enforceable against the parties and their respective successors and assigns.

 

12.         Third
Party Beneficiaries. This Agreement is intended solely for the benefit of the parties hereto and, with the exception of the
rights and benefits conferred upon the Consultant Indemnified Parties by Section 6 of this Agreement, shall not be deemed or interpreted
to confer any rights upon any third parties.

 

13.         Governing
Law; Jurisdiction; Venue. All aspects of the relationship created by this Agreement shall be governed by and construed in
accordance with the laws of the State of California, applicable to contracts made and to be performed in California, without regard
to its conflicts of laws provisions. All actions and proceedings which are not submitted to arbitration pursuant to Section 14
hereof shall be heard and determined exclusively in the state and federal courts located in the County of Los Angeles, State of
California, and the Company and Consultant hereby submit to the jurisdiction of such courts and irrevocably waive any defense
or objection to such forum, on forum non conveniens grounds or otherwise.

 

14.         Arbitration.
Any dispute, claim or controversy arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation
or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be determined
by arbitration before one arbitrator in Los Angeles (with the exception of claims to enforce the indemnity provision contained
herein, administered by JAMS pursuant to its Streamlined Arbitration Rules and Procedures. Judgment on the Award may be entered
in any court having jurisdiction. This clause shall not preclude parties from seeking provisional remedies in aid of arbitration
from a court of appropriate jurisdiction.

 

    	9

    	 

    
 

 

The arbitrator may,
in the award, allocate all or part of the costs of the arbitration, including the fees of the arbitrator and the reasonable attorneys’
fees of the prevailing party.

 

The parties hereby
agree that this Section 14 shall survive the termination and/or expiration of this Agreement.

 

The Company’s
and Consultant’s consent to Arbitration are confirmed by initialing below:

 

	 	 	 	 	 
	 	Company	 	Consultant	 

 

15.         Severability.
Should any one or more covenants, restrictions and provisions contained in this Agreement be held for any reason to be void, invalid
or unenforceable, in whole or in part, such unenforceability will not affect the validity of any other term of this Agreement,
and the invalid provision will be binding to the fullest extent permitted by law and will be deemed amended and construed so as
to meet this intent. To the extent any provision cannot be so amended or construed as a matter of law, the validity of the remaining
provisions shall be deemed unaffected and the illegal or invalid provision will be deemed stricken from this Agreement.

 

16.         Section
Headings. The section headings herein are for convenience of reference only, and shall not limit or otherwise affect the meaning
hereof.

 

17.         Accounting.
Any calculation, computation or accounting that may be required under this Agreement shall be made in accordance and conformity
with the Generally Accepted Accounting Principles and other standards as determined by the Financial Accounting Standards board
and regulatory agencies with appropriate jurisdiction.

 

18.         Counterparts.
This Agreement may be executed via facsimile transmission and may be executed in separate counterparts, each of which shall be
deemed to be an original and all of which together shall constitute a single instrument.

 

If the above accords
with your understanding and agreement, kindly indicate your consent hereto by signing below. We look forward to a long and successful
relationship with you.

 

    	10

    	 

    

 

 

	 	 	 	Very truly yours,
	 	 	 	 	 
	 	 	 	Liquid Patent Consulting, LLC
	 	 	 	 
	 	 	 	By: 	 
	 	 	 	 	Ankur Desai
	 	 	 	 	Founding Partner
	 	 	 	 	 
	ACCEPTED AND AGREED TO	 	 	 
	AS OF THE DATE FIRST ABOVE WRITTEN:	 	 	 
	 	 	 	 	 
	Aqua Metals, Inc.	 	 	 
	 	 	 	 	 
	By:	 	 	 	 

 

    	11

    	 

    

 

 

 

EXHIBIT A

 

Work Assignment

 

Services

 

Payment of Fees 

Bill Rate:

 

AGREED TO:

Liquid Patent Consulting, LLC

	By:	 	 
	Title:	 	 
	Date:	 	 
	 	 	 
	Aqua Metals, Inc.	 
	By:	 	 
	Title:	 	 
	Date:	 	 

 

    	12

    	 

    

 

 

 

EXHIBIT B

 

SCHEDULE OF FEES

 

	Nature of IP Service	 	Fee
	 	 	 
	Review and analysis of inventions held by the Company to determine their usefulness, potential for monetization and potential patentability, including advice concerning the increase in the likelihood or strength of any of the foregoing;	 	 
	 	 	 
	Interviewing Company to understand the subject inventions and researching prior art for purposes of determining the patentability of such inventions;	 	 
	 	 	 
	Advise and assist in developing a strategy for the preparation and filing of one or more patents, both United States and foreign, for purposes of adequately protecting the substantive claims underlying the inventions	 	 
	 	 	 
	Review and comment on patent applications filed with respect to such inventions;	 	 
	 	 	 
	Review and comment on office actions concerning patent applications and issued patents;	 	 
	 	 	 
	Advise and assist in developing a strategy for the Company’s strategic acquisitions of inventions and patent rights to enhance the Company’s portfolio of patent rights, including conducting the due diligence and acquisition efforts on behalf of the Company;	 	 
	 	 	 
	Advise and assist with regard to licensing, litigation and sales of patent rights held by the Company	 	 
	 	 	 
	Provide engineering and/or scientific advisory services to the Company	 	 

 

    	 

    	 

    

 

 

 

EXHIBIT C

 

FORM OF WARRANT

 

NEITHER THESE SECURITIES NOR THE SECURITIES
ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”) AND APPLICABLE STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO (I) AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR (II) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS.
THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

[Name of Issuer]

 

WARRANT TO PURCHASE COMMON STOCK

 

	Warrant No.__	Original Issue Date: __________, 2014

 

_________, a ___________
corporation (the “Company”), hereby certifies that, for value received, Liquid Patent Consulting, LLC
or its permitted registered assigns (the “Holder”), is entitled to purchase from the Company up to a
total of _____ shares of common stock, $ _______ par value (the “Common Stock”), of the Company
(each such share, a “Warrant Share” and all such shares, the “Warrant Shares”)
at an exercise price per share equal to $0.01 (as adjusted from time to time as provided in Section 9 herein, the “Exercise
Price”), at any time and from time to time from on or after the date hereof (the “Trigger Date”)
and through and including 5:00 P.M., prevailing Pacific time, on ______, 2017 (the “Expiration Date”),
and subject to the following terms and conditions:

 

This Warrant (this
“Warrant”) is one of a series of similar warrants issued pursuant to that certain Engagement Agreement
for Strategic Consulting Services dated _____, 2014 between the Company and the Holder (the “Consulting
Agreement”). All such warrants are referred to herein, collectively, as the “Warrants.”

 

    	 

    	 

    

 

 

1.          Definitions.         In
addition to the terms defined elsewhere in this Warrant, capitalized terms that are not otherwise defined herein have the meanings
given to such terms in the Consulting Agreement.

 

2.          Registration
of Warrants. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant
Register”), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any
registered assignee to which this Warrant is permissibly assigned hereunder) from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to
the Holder, and for all other purposes, absent actual notice to the contrary.

 

3.          Registration
of Transfers. The Company shall register the transfer of all or any portion of this Warrant in
the Warrant Register, upon (i) surrender of this Warrant, with the Form of Assignment attached as Schedule 2 hereto duly
completed and signed, to the Company’s transfer agent or to the Company at its address specified herein (ii) delivery, at
the request of the Company, of an opinion of counsel reasonably satisfactory to the Company to the effect that the transfer of
such portion of this Warrant may be made pursuant to an available exemption from the registration requirements of the Securities
Act of 1933 (“Securities Act”) and all applicable state securities or blue sky laws and (iii) delivery
by the transferee of a written statement to the Company certifying that the transferee is an “accredited investor”
as defined in Rule 501(a) under the Securities Act and making the representations and certifications as the Company may reasonably
request to procure an exemption from section 5 of the Securities Act. Upon any such registration or transfer, a new warrant to
purchase Common Stock in substantially the form of this Warrant (any such new warrant, a “New Warrant”)
evidencing the portion of this Warrant so transferred shall be issued to the transferee, and a New Warrant evidencing the remaining
portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Warrant
by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations of a Holder of
a Warrant.

 

4          Exercise and
Duration of Warrants.

 

(a)          All
or any part of this Warrant shall be exercisable by the registered Holder at any time and from time to time on or after the Trigger
Date and through and including 5:00 P.M. prevailing Pacific time on the Expiration Date. At 5:00 P.M., prevailing Pacific time,
on the Expiration Date, the portion of this Warrant not exercised prior thereto shall be and become void and of no value and this
Warrant shall be terminated and no longer outstanding.

 

    	 

    	 

    

 

 

(b)          The
Holder may exercise this Warrant by delivering to the Company (i) an exercise notice, in the form attached as Schedule 1 hereto
(the “Exercise Notice”), appropriately completed and duly signed, (ii) payment of the Exercise Price
for the number of Warrant Shares as to which this Warrant is being exercised (which may take the form of a “cashless exercise”
if so indicated in the Exercise Notice and if a “cashless exercise” may occur at such time pursuant to Section 10
below), and the date such items are delivered to the Company (as determined in accordance with the notice provisions hereof) is
an “Exercise Date.” The Holder shall not be required to deliver the original Warrant in order
to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall have the same effect as cancellation of the
original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number of Warrant Shares.

 

5.          Delivery
of Warrant Shares. Upon exercise of this Warrant, the Company shall promptly issue or cause to be issued and cause to be delivered
to or upon the written order of the Holder and in such name or names as the Holder may designate a certificate for the Warrant
Shares issuable upon such exercise, with an appropriate restrictive legends. The Holder, or any Person permissibly so designated
by the Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant Shares as of the Exercise
Date.

 

6.          Charges,
Taxes and Expenses. Issuance and delivery of certificates for shares of Common Stock upon exercise of this Warrant shall be
made without charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax or expense in respect
of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company; provided, however,
that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the registration
of any certificates for Warrant Shares or Warrants in a name other than that of the Holder or an Affiliate thereof. The Holder
shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving
Warrant Shares upon exercise hereof.

 

7.          Replacement
of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon
receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case) and, in each case,
a customary and reasonable indemnity (which shall not include a surety bond), if requested. Applicants for a New Warrant under
such circumstances shall also comply with such other reasonable regulations and procedures and pay such other reasonable third-party
costs as the Company may prescribe. If a New Warrant is requested as a result of a mutilation of this Warrant,
then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company’s obligation
to issue the New Warrant.

 

    	 

    	 

    
 

 

8.          Reservation
of Warrant Shares. The Company covenants that it will at all times reserve and keep available out of the aggregate of its
authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon
exercise of this Warrant as herein provided, the number of Warrant Shares which are then issuable and deliverable upon the exercise
of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the Holder (taking
into account the adjustments and restrictions of Section 9). The Company covenants that all Warrant Shares so issuable
and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be
duly and validly authorized, issued and fully paid and nonassessable. The Company will take all such action as may be necessary
to assure that such shares of Common Stock may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of any securities exchange or automated quotation system upon which the Common Shares may be listed.

 

9.          Certain
Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment
from time to time as set forth in this Section 9.

 

(a)          Stock
Dividends and Splits. If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on its Common
Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides
its outstanding shares of Common Stock into a larger number of shares, or (iii) combines its outstanding shares of Common Stock
into a smaller number of shares, then in each such case the Exercise Price shall be multiplied by a fraction, the numerator of
which shall be the number of shares of Common Stock outstanding immediately before such event and the denominator of which shall
be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of
this paragraph shall become effective immediately after the record date for the determination of stockholders entitled to receive
such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately
after the effective date of such subdivision or combination.

 

    	 

    	 

    

 

 

(b)          Fundamental
Transactions. If, at any time while this Warrant is outstanding (i) the Company effects any merger or consolidation of the
Company with or into another Person, in which the Company is not the survivor, (ii) the Company
effects any sale of all or substantially all of its assets or a majority of its Common Stock is acquired by a third party, in
each case, in one or a series of related transactions, (iii) any tender offer or exchange offer (whether by the Company or another
Person) is completed pursuant to which all or substantially all of the holders of Common Stock are permitted to tender or exchange
their shares for other securities, cash or property, or (iv) the Company effects any reclassification of the Common Stock or any
compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of shares of Common Stock covered by Section 9(a) above)
(in any such case, a “Fundamental Transaction”), then the Holder shall have the right thereafter to
receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled
to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction,
the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant without regard to any limitations
on exercise contained herein (the “Alternate Consideration”). The Company shall not effect
any such Fundamental Transaction unless prior to or simultaneously with the consummation thereof, any successor to the Company,
surviving entity or the corporation purchasing or otherwise acquiring such assets or other appropriate corporation or entity shall
assume the obligation to deliver to the Holder, such Alternate Consideration as, in accordance with the foregoing provisions,
the Holder may be entitled to purchase and/or receive (as the case may be), and the other obligations under this Warrant. The
provisions of this paragraph (c) shall similarly apply to subsequent transactions analogous to a Fundamental Transaction.

 

(c)          Number
of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to paragraph (a) of this Section, the
number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so
that after such adjustment the aggregate Exercise Price payable hereunder for the increased or decreased number of Warrant Shares
shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.

 

(d)          Calculations.
All calculations under this Section 9 shall be made to the nearest cent or the nearest 1/100th of a share, as
applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for
the account of the Company, and the sale or issuance of any such shares shall be considered an issue or sale of Common Stock.

 

    	 

    	 

    

 

 

(e)          Notice
of Adjustments. Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its expense will,
at the written request of the Holder, promptly compute such adjustment, in good faith, in accordance with the terms of this Warrant
and prepare a certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted number
or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions
giving rise to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the
Company will promptly deliver a copy of each such certificate to the Holder and to the Company’s transfer agent.

 

(f)          Notice
of Corporate Events. If, while this Warrant is outstanding, the Company (i) declares a dividend or any other distribution
of cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or
warrants to subscribe for or purchase any capital stock of the Company, (ii) authorizes or approves, enters into any agreement
contemplating or solicits stockholder approval for any Fundamental Transaction or (iii) authorizes the voluntary dissolution,
liquidation or winding up of the affairs of the Company, then, except if such notice and the contents thereof shall be deemed
to constitute material non-public information, the Company shall deliver to the Holder a notice describing the material terms
and conditions of such transaction at least ten (10) Trading Days prior to the applicable record or effective date on which a
Person would need to hold Common Stock in order to participate in or vote with respect to such transaction, and the Company will
take all steps reasonably necessary in order to insure that the Holder is given the practical opportunity to exercise this Warrant
prior to such time so as to participate in or vote with respect to such transaction; provided, however, that the failure
to deliver such notice or any defect therein shall not affect the validity of the corporate action required to be described in
such notice.

 

10.         Payment
of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds; provided, however, the Holder
may, in its sole discretion, commencing on the date that is 18 months from the date of this Warrant,
satisfy its obligation to pay the Exercise Price through a “cashless exercise”, in which event the Company shall issue
to the Holder the number of Warrant Shares determined as follows:

 

X = Y [(A-B)/A]

 

where:

 

X = the number
of Warrant Shares to be issued to the Holder.

 

Y = the total
number of Warrant Shares with respect to which this Warrant is being exercised.

 

A = the average
of the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) for the five Trading Days
ending on the date immediately preceding the Exercise Date.

 

B = the Exercise
Price then in effect for the applicable Warrant Shares at the time of such exercise.

 

    	 

    	 

    

 

 

For purposes of this Warrant, “Closing
Sale Price” means, for any security as of any date, the last trade price for such security on the principal securities
exchange or trading market for such security, as reported by Bloomberg Financial Markets, or, if such exchange or trading market
begins to operate on an extended hours basis and does not designate the last trade price, then the last trade price of such security
prior to 4:00:00 p.m., New York Time, as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last trade
price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg
Financial Markets, or, if no last trade price is reported for such security by Bloomberg Financial Markets, the average of the
bid prices, or the ask prices, respectively, of any market makers for such security as reported in the “pink sheets”
by Pink Sheets LLC. If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing
bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company
and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then the Company
shall, within two business days submit via facsimile (a) the disputed determination of the Warrant Exercise Price to an independent,
reputable investment bank selected by the Company and approved by the Holder or (b) the disputed arithmetic calculation of the
Warrant Shares to the Company’s independent, outside accountant. The Company shall cause at its expense the investment bank
or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of
the results no later than ten business days from the time it receives the disputed determinations or calculations. Such investment
bank’s or accountant’s determination or calculation, as the case may be, shall be binding upon all parties absent
demonstrable error. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination
or other similar transaction during the applicable calculation period.

 

For purposes of Rule 144 promulgated under
the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction
shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced,
on the date this Warrant was originally issued pursuant to the Consulting Agreement (provided that the Commission continues to
take the position that such treatment is proper at the time of such exercise).

 

    	 

    	 

    

 

 

11.         Limitation
on Exercises. In the event that the Company registers the sale of any of its securities pursuant to the Securities Act of 1933,
as amended, as an initial public offering, in an transaction that is subject FINRA review for compensation purposes, where the
Holder is, or an affiliate of, a distribution participant for the offering, then this Warrant may not be exercised for 90 days
after the effective date of the initial registration statement under that act. Additionally, the Company shall not effect the exercise
of this Warrant, and the Holder shall not have the right to exercise this Warrant, to the extent that after giving effect to such
exercise, the Holder (together with such Holder’s affiliates) would beneficially own in excess of 4.99% (“Maximum
Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes
of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Holder and its affiliates
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination
of such sentence is being made, but shall exclude shares of Common Stock which would be issuable upon (A) exercise of the remaining,
unexercised portion of this Warrant beneficially owned by such Holder and its affiliates and (B) exercise or conversion of the
unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates
(including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion
or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph,
beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended. To
the extent that the limitation contained in this Section 11 applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any affiliate) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any affiliate)
and of which portion of this Warrant is exercisable, in each case subject to such aggregate percentage limitation, and the Company
shall have no obligation to verify or confirm the accuracy of the determination. For purposes of this Warrant, in determining the
number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as reflected
in (1) the Company’s most recent Form 10-K, Form 10-Q, Current Report on Form 8-K or other
public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company
or (3) any other notice by the Company setting forth the number of shares of Common Stock outstanding, For any reason at any time,
upon the written or oral request of the Holder, the Company shall within one (1) business day confirm orally and in writing to
the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock
shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by
the Holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written
notice to the Company, any Holder may decrease the Maximum Percentage to any other percentage specified in such notice; provided
that such decrease will apply only to the Holder sending such notice and not to any other holder of Warrants. In addition, by written
notice to the Company, any Holder may remove the limitations on exercises provided in this Section 11 entirely; provided that (i)
any such removal will not be effective until the 61st day after such notice is delivered to the Company, and (ii) any such removal
will apply only to the Holder sending such notice and not to any other holder of Warrants. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 11 to correct this
paragraph (or any portion hereof) which may be defective or inconsistent with the intended beneficial ownership limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.

    	 

    	 

    

 

 

12.         No
Fractional Shares. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of
any fractional shares which would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded up to the next
whole number.

 

13.         Notices.
Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall
be in writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication
is delivered via email at the email address specified in the Consulting Agreement prior to 5:00 p.m. (prevailing Pacific time)
on a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via email
at the email address specified in the Consulting Agreement t on a day that is not a Trading Day or later than 5:00 p.m. (prevailing
Pacific time) on any Trading Day, (iii) the Trading Day following the date of mailing, if sent by nationally recognized overnight
courier service specifying next business day delivery, or (iv) upon actual receipt by the party to whom such notice is required
to be given, if by hand delivery. The address and facsimile number of a party for such notices or communications shall be as set
forth in the Consulting Agreement unless changed by such party by two Trading Days” prior notice to the other party in accordance
with this Section 13.

 

14.         Warrant
Agent. The Company shall serve as warrant agent under this Warrant. Upon thirty (30) days’ notice to the Holder, the
Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation
resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the
Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be
a successor warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice
of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder
at the Holder’s last address as shown on the Warrant Register.

 

    	 

    	 

    

 

 

15.         Registration
Rights. The Company agrees that the Holder and its assigns will have registration rights covering the resale of the Warrant
Shares, including “piggyback” registration rights on the registrations of the Company or demand registrations
(voting with the other registrable securities to effect any such demand), no less favorable than those granted to any other person
by the Company prior or subsequent to the date of this Warrant. At such time, and from time to time, as the Company enters into
an agreement subsequent to the date of this Warrant pursuant to which the Company grants any third party rights with respect to
the Company’s registration of Company securities under the Securities Act held by such party, the Company shall offer to
enter into a formal written registration rights agreement with the Holder and its assigns on substantially the same terms and such
other terms as are customary and usual for agreements of such nature. In addition to, and without restricting or limiting the scope
of this subparagraph (a), the Company further agrees that:

 

(a)          Right
to Piggyback. Whenever the Company proposes to register any of its securities under the Securities Act, the Company will give
prompt written notice to the Holder of its intention to effect such registration and will include in such registration all Warrant
Shares with respect to which the Company has received a written request from the Holder for inclusion therein within 15 days after
the receipt of the Company’s notice. The Company will pay, or cause to be paid, the registration expenses of the Holder in
all piggyback registrations.

 

(b)          Underwritten
Offering. If a piggyback registration is an underwritten primary or secondary registration on behalf of the Company and/or
other holders of the Common Stock, and the managing underwriters advise the Company in writing that in their opinion the number
of shares requested to be included in such registration (including the Warrant Shares and any other shares of Common Stock held
by holders with registration rights) exceeds the number which can be sold in such offering without materially and adversely affecting
the marketability of the offering, the Company will promptly furnish the Holder with a copy of the underwriter’s opinion
and may, by written notice to the Holder, include in such registration (i) first, the securities the Company proposes to sell,
and (ii) second, the Common Stock requested to be included in such registration pro rata among all holders with registration rights
on the basis of the number of shares owned by each such holder.

 

(c)          Underwriting
Agreement. In any registration in which the Warrant Shares is to be included, the Holder shall be a party to the underwriting
agreement entered into by the Company in connection therewith, and the representations and warranties by, and the other agreements
on the part of, the Company and for the benefit of the underwriters shall also be made to and for
the benefit of the Holder.

 

    	 

    	 

    

 

 

(d)          Documents,
etc. The Company shall provide to the Holder any and all documents, statements, opinions and forms as the Holder reasonably
deems necessary for the Holder to participate in any piggyback registrations and to facilitate the disposition of the Warrant Shares
covered by such registration pursuant to the terms and conditions of this Agreement and the applicable securities laws.

 

(e)          Indemnification.
In the event of any piggyback registration of any Warrant Shares under the Securities Act, and in connection with any registration
statement or any other disclosure document pursuant to which securities of the Company are sold, the Company will, and hereby does,
jointly and severally, indemnify and hold harmless the Holder, its directors, officers, members, fiduciaries, and agents (each,
a “Covered Person”) against any losses, claims, damages or liabilities, joint or several, to which such
Covered Person may be or become subject under the Securities Act, any other securities or other laws of any jurisdiction, common
law or otherwise, insofar as such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) arise out
of or are based upon (1) any untrue statement or alleged untrue statement of any material fact contained or incorporated by reference
in any registration statement under the Securities Act, any preliminary prospectus or final prospectus included therein, or any
amendment or supplement thereto, or any document incorporated by reference therein, or any other such disclosure document, or (2)
any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement
therein not misleading, and will reimburse such Covered Person for any legal or any other expenses incurred by in connection with
investigating or defending any such loss, claim, damage, liability, action or proceeding; provided, however, the Company
shall not be liable to any Covered Person in any such case to the extent that any such loss, claim, damage, liability, action or
proceeding arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made
in such registration statement, any such preliminary prospectus, final prospectus, amendment or supplement, any document incorporated
by reference or other such disclosure document in reliance upon and in conformity with written information furnished to the Company
through an instrument duly executed by such Covered Person specifically stating this it is for use in the preparation thereof.

 

(f)          All
fees and expenses incurred by the Company in connection with the performance of its obligation to register the Warrant Shares pursuant
to Section 15 shall be borne by the Company; provided that any fees and expenses of the holder or holders thereof or of
its or their counsel, and transfer taxes applicable to the sale of such Warrant Shares, shall be
borne by such holder or holders.

    	 

    	 

    
 

 

16.         Miscellaneous.

 

(a)          The
Holder, solely in such Person’s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends
or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed
to confer upon the Holder, solely in such Person’s capacity as the Holder of this Warrant, any of the rights of a stockholder
of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock,
reclassification of stock, consolidation, merger, amalgamation, conveyance or otherwise), receive notice of meetings, receive dividends
or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing
any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the
Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 16(a),
the Company shall provide the Holder with copies of the same notices and other information given to the shareholders of the Company,
contemporaneously with the giving thereof to the shareholders.

 

(b)          Subject
to the restrictions on transfer set forth on the first page hereof, and compliance with applicable securities laws, this Warrant
may be assigned by the Holder. This Warrant may not be assigned by the Company except to a successor in the event of a Fundamental
Transaction. This Warrant shall be binding on and inure to the benefit of the parties hereto and their respective successors and
assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the Company
and the Holder any legal or equitable right, remedy or cause of action under this Warrant. This Warrant may be amended only in
writing signed by the Company and the Holder, or their successors and assigns.

    	 

    	 

    

 

 

(c)          GOVERNING
LAW; VENUE; WAIVER OF JURY TRIAL. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS WARRANT
SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF CALIFORNIA WITHOUT REGARD TO THE PRINCIPLES
OF CONFLICTS OF LAW THEREOF. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS
SITTING IN THE CITY OF LOS ANGELES, CALIFORNIA, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH
ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT
OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING,
ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER.
EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION
OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH
PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT
SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS
IN ANY MANNER PERMITTED BY LAW. THE COMPANY HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.

 

(d)          The
headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any
of the provisions hereof.

 

(e)          In
case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability
of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby, and the parties will
attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor,
and upon so agreeing, shall incorporate such substitute provision in this Warrant.

 

(f)          Except
as otherwise set forth herein, prior to exercise of this Warrant, the Holder hereof shall not, by reason of by being a Holder,
be entitled to any rights of a stockholder with respect to the Warrant Shares.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK,

SIGNATURE PAGE FOLLOWS]

 

    	 

    	 

    

 

 

 

IN WITNESS WHEREOF, the Company has caused
this Warrant to be duly executed by its authorized officer as of the date first indicated above.

 

	 	 
	 	 	 
	 	By:	 
	 	 	(Name and Title)

 

    	 

    	 

    

 

 

 

SCHEDULE 1

FORM OF EXERCISE NOTICE

 

(To be executed by the Holder to exercise
the right to purchase shares of Common Stock under the foregoing Warrant)

 

Ladies and Gentlemen:

 

(1)         The
undersigned is the Holder of Warrant No. _________ (the “Warrant”) issued by _____________, a _______ corporation
(the “Company”). Capitalized terms used herein and not otherwise defined herein have the respective meanings
set forth in the Warrant.

 

(2)         The
undersigned hereby exercises its right to purchase __________ Warrant Shares pursuant to the Warrant.

 

(3)         The
Holder intends that payment of the Exercise Price shall be made as (check one):

 

Cash Exercise

 

“Cashless Exercise”
under Section 10

 

(4)         If
the Holder has elected a Cash Exercise, the Holder shall pay the sum of $_______ in immediately available funds to the Company
in accordance with the terms of the Warrant.

 

(5)         Pursuant
to this Exercise Notice, the Company shall deliver to the Holder ________ Warrant Shares in accordance with the terms of the Warrant.

 

Dated:_____________, ______

Name of Holder: __________________________

By: __________________________

Name: __________________________

Title: __________________________

(Signature must conform in all respects
to name of Holder as specified on the face of the Warrant)

 

    	 

    	 

    

 

 

 

SCHEDULE 2

 

______________________________.

 

FORM OF ASSIGNMENT

 

[To be completed and signed only upon transfer
of Warrant]

 

FOR VALUE RECEIVED, the undersigned hereby
sells, assigns and transfers unto _______ (the “Transferee” the right represented by the within Warrant
to purchase ________ shares of Common Stock of ________________ (the “Company”) to which the within Warrant
relates and appoints _________ attorney to transfer said right on the books of the Company with full power of substitution in the
premises. In connection therewith, the undersigned represents, warrants, covenants and agrees to and with the Company that:

(a)          the
offer and sale of the Warrant contemplated hereby is being made in compliance with Section 4(1) of the United States Securities
Act of 1933, as amended (the “Securities Act”) or another valid exemption from the registration
requirements of Section 5 of the Securities Act and in compliance with all applicable securities laws of the states of the United
States;

(b)          the
undersigned has not offered to sell the Warrant by any form of general solicitation or general advertising, including, but not
limited to, any advertisement, article, notice or other communication published in any newspaper, magazine or similar media or
broadcast over television or radio, and any seminar or meeting whose attendees have been invited by any general solicitation or
general advertising;

(c)          the
undersigned has read the Transferee’s investment letter included herewith, and to its actual knowledge, the statements made
therein are true and correct; and

(d)          the
undersigned understands that the Company may condition the transfer of the Warrant contemplated hereby upon the delivery to the
Company by the undersigned or the Transferee, as the case may be, of a written opinion of counsel (which opinion shall be in form,
substance and scope customary for opinions of counsel in comparable transactions) to the effect that such transfer may be made
without registration under the Securities Act and under applicable securities laws of the states of the United States.

	 	 
	 		 

  

    	 

    	 

    
 

 

	Dated _____,__	 
	 	(Signature must conform in all respects to name of holder as specified on the face of the Warrant)
	 	 
	 	 
	 	Address of Transferee
	 	 
	 	 
	 	 
	 	 
	In the presence of:Exhibit 10.4

 

SECURITIES
PURCHASE AGREEMENT

 

This SECURITIES
PURCHASE AGREEMENT (this “Agreement”), dated as of October 31, 2014 (the “Effective Date”),
is by and among Aqua Metals, Inc., a Delaware corporation (the “Company”), and the investors that have executed
this Agreement and are listed on the Schedule of Buyers, attached hereto as Exhibit A (individually, a “Buyer”
and collectively, the “Buyers”).

 

RECITALS

 

A.           The
Company and each Buyer is executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”), and Rule 506 of Regulation D
(“Regulation D”), as promulgated by the United States Securities and Exchange Commission (the “SEC”)
under the 1933 Act.

 

B.           The
Company has authorized the issuance of senior secured convertible notes in the aggregate original principal amount of up to $4,500,000,
in the form attached hereto as Exhibit B (the “Notes”), which Notes shall be convertible into
shares of Common Stock (as defined in the Notes) (as converted, collectively, the “Conversion Shares”), in accordance
with the terms of the Notes.

 

C.           Each
Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, the aggregate
original principal amount of the Notes set forth opposite such Buyer’s name in column (2) on the Schedule of Buyers.

 

D.           At
the Closing, the parties hereto shall execute and deliver a Registration Rights Agreement, in the form attached hereto as Exhibit
C (the “Registration Rights Agreement”), pursuant to which the Company has agreed to provide certain
registration rights with respect to the Registrable Securities (as defined in the Registration Rights Agreement), under the 1933
Act and the rules and regulations promulgated thereunder, and applicable state securities laws.

 

E.           In
connection with the Offering, the Company, together with National Securities Corporation (the “Placement Agent”),
have entered into an escrow agreement, in the form attached hereto as Exhibit D (the “Escrow Agreement”),
with U.S. Bank National Association (the (“Escrow Agent”), to hold the Purchase Price (as hereinafter defined),
to be released at the Closing to the Company, upon the written consent of the Company and the Placement Agent.

 

F.           The
Notes and the Conversion Shares are collectively referred to herein as the “Securities.”

 

G.           The
Notes will be secured by a first priority perfected security interest in all the assets of the Company as evidenced by a security
agreement in the form attached hereto as Exhibit E (the “Security Agreement” and together with
the other security documents and agreements entered into in connection with this Agreement and each of such other documents and
agreements, as each may be amended or modified from time to time, collectively, the “Security Documents”).

 

    	 

    	 

    

  

AGREEMENT

 

NOW, THEREFORE, in
consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Company and each Buyer hereby agree as follows:

 

		1.	PURCHASE AND SALE OF NOTES AND WARRANTS.

 

(a)          Notes.
Subject to the satisfaction (or waiver) of the conditions set forth in Sections 6 and 7 below, the Company shall issue and sell
to each Buyer, and each Buyer severally, but not jointly, shall purchase from the Company on the Closing Date (as defined below),
a Note in the original principal amount as is set forth opposite such Buyer’s name in column (2) on the Schedule of Buyers.

 

(b)          Closing.
The closing (the “Closing”) of the purchase of the Notes by the Buyers shall occur at the offices of Greenberg
Traurig, LLP, 3161 Michelson Drive, Suite 1000, Irvine, CA 92612. The date and time of the Closing (the “Closing Date”)
shall be 11:00 a.m., New York time, on the first Business Day on which the conditions to the Closing set forth in Sections 6 and
7 below are satisfied or waived (or such later date as is mutually agreed to by the Company and each Buyer). As used herein “Business
Day” means any day other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized
or required by law to remain closed.

 

(c)          Purchase
Price. The purchase price for each Note to be purchased by each Buyer (the “Purchase Price”) shall be equal
to the original principal amount of the Note set forth opposite such Buyer’s name in column (2) on the Schedule of Buyers.

 

(d)          Payment
of Purchase Price; Delivery of Notes. On the Closing Date, (i) each Buyer shall pay its respective Purchase Price to the Company
through the Escrow Agent for their respective Note to be issued and sold to such Buyer at the Closing, and (ii) the Company shall
deliver to each Buyer a Note (in such amount as is set forth opposite such Buyer’s name in column (2) on the Schedule of
Buyers), in all cases, duly executed on behalf of the Company and registered in the name of such Buyer or its designee.

 

		2.	BUYER’S REPRESENTATIONS AND WARRANTIES.

 

Each Buyer represents and warrants to the
Company with respect to only itself that:

 

(a)          Organization;
Authority. Such Buyer (i) if an entity, is duly organized, validly existing and in good standing under the laws of the jurisdiction
of its organization with the requisite power and authority to enter into and to consummate the transactions contemplated by the
Transaction Documents (as defined below) to which it is a party and otherwise to carry out its obligations hereunder and thereunder,
or (ii) if an individual, has the legal capacity to enter into and to consummate the transactions contemplated by the Transaction
Documents to which it is a party and otherwise to carry out its obligations hereunder and thereunder.

 

    	2

    	 

    

  

(b)          No
Public Sale or Distribution. Such Buyer (i) is acquiring its Note, and (ii) upon conversion of its Note will acquire the Conversion
Shares issuable upon conversion thereof, in each case, for its own account and not with a view towards, or for resale in connection
with, the public sale or distribution thereof in violation of applicable securities laws, except pursuant to sales registered or
exempted under the 1933 Act; provided, however, by making the representations herein, such Buyer does not agree, or make any representation
or warranty, to hold any of the Securities for any minimum or other specific term and reserves the right to dispose of the Securities
at any time in accordance with or pursuant to a registration statement or an exemption under the 1933 Act. Such Buyer does not
presently have any agreement or understanding, directly or indirectly, with any Person (as defined below) to distribute any of
the Securities in violation of applicable securities laws.

 

(c)          Accredited
Investor Status. Such Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D.

 

(d)          Reliance
on Exemptions. Such Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon
the truth and accuracy of, and such Buyer’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of such Buyer set forth herein in order to determine the availability of such exemptions and the eligibility
of such Buyer to acquire the Securities.

 

(e)          Information.
Such Buyer and its advisors, if any, have been furnished with the Company’s private placement memorandum dated October 2,
2014 (the “Private Placement Memorandum”) and with all other materials relating to the business, finances and
operations of the Company and materials relating to the offer and sale of the Securities which have been requested by such Buyer.
Such Buyer and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Such Buyer understands
that its investment in the Securities involves a high degree of risk. Such Buyer has sought such accounting, legal and tax advice
as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities.

 

(f)          No
Governmental Review. Such Buyer understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment
in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

(g)          Transfer
or Resale. Such Buyer understands that except as provided in the Registration Rights Agreement or Section 4(h) hereof: (i)
the Securities have not been and are not being registered under the 1933 Act or any state securities laws, and may not be offered
for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) such Buyer shall have delivered to the
Company (if requested by the Company) an opinion of counsel to such Buyer, in a form reasonably acceptable to the Company, to the
effect that such Securities to be sold, assigned or transferred may be sold, assigned or transferred pursuant to an exemption from
such registration, or (C) such Buyer provides the Company with reasonable assurance and documentation as may be requested by the
Company or its legal counsel that such Securities can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A promulgated
under the 1933 Act (or a successor rule thereto) (collectively, “Rule 144”); (ii) any sale of the Securities
made in reliance on Rule 144 may be made only in accordance with the terms of Rule 144, and further, if Rule 144 is not applicable,
any resale of the Securities under circumstances in which the seller (or the Person through whom the sale is made) may be deemed
to be an underwriter (as that term is defined in the 1933 Act) may require compliance with some other exemption under the 1933
Act or the rules and regulations of the SEC promulgated thereunder; and (iii) neither the Company nor any other Person is under
any obligation to register the Securities under the 1933 Act or any state securities laws or to comply with the terms and conditions
of any exemption thereunder.

 

    	3

    	 

    

  

(h)          Validity;
Enforcement. This Agreement and the other Transaction Documents executed by the Buyer have been duly and validly authorized,
executed and delivered on behalf of such Buyer and constitutes the legal, valid and binding obligations of such Buyer enforceable
against such Buyer in accordance with their respective terms, except as such enforceability may be limited by general principles
of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or
affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

(i)          No
Conflicts. The execution, delivery and performance by such Buyer of this Agreement and the other Transaction Documents executed
by the Buyer and the consummation by such Buyer of the transactions contemplated hereby and thereby will not (i) result in a violation
of the organizational documents of such Buyer, (ii) conflict with, or constitute a default (or an event which with notice or lapse
of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture or instrument to which such Buyer is a party or (iii) result in a violation of any law, rule, regulation,
order, judgment or decree (including federal and state securities laws) applicable to such Buyer, except in the case of clauses
(ii) and (iii) above, for such conflicts, defaults, rights or violations which would not, individually or in the aggregate, reasonably
be expected to have a material adverse effect on the ability of such Buyer to perform its obligations hereunder.

 

(j)          Buyer’s
Principal Residence/Office. The address of Buyer’s principal residence, if Buyer is a natural Person, or principal office,
if Buyer is a non-natural Person, such as a corporation, limited liability company or other entity, is set forth on the Buyer’s
signature page hereto.

 

(k)          No
Engagements. Such Buyer has not engaged any brokers, finders or agents, and the Company has not, nor will, incur, directly
or indirectly, as a result of any action taken by such Buyer, any liability for brokerage or finders’ fees or agents’
commissions or any similar charges in connection with the transactions consummated under this Agreement. Neither such Buyer, nor
any of Buyer’s officers, directors, employees, agents, stockholders or partners has either directly or indirectly, including
through a broker or finder: (i) engaged in or received any general solicitation or (ii) published or received any advertisement
in connection with the offer or sale of the Securities.

 

    	4

    	 

    

  

		3.	REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

 

The Company represents and warrants to each
of the Buyers that:

 

(a)          Organization
and Qualification. The Company is an entity duly organized and validly existing and in good standing under the laws of the
jurisdiction in which it is formed, and has the requisite power and authorization to own its properties and to carry on its business
as now being conducted and as presently proposed to be conducted. The Company is duly qualified as a foreign entity to do business
and is in good standing in every jurisdiction in which its ownership of property or the nature of the business conducted by it
makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing would not be
reasonably expected to have a Material Adverse Effect. “Material Adverse Effect” means any material adverse
effect on (i) the business, properties, assets, liabilities, operations (including results thereof) or condition (financial or
otherwise) of the Company, either individually or taken as a whole, (ii) the transactions contemplated hereby or in any of the
other Transaction Documents, or (iii) the authority or ability of the Company to perform any of its obligations under any of the
Transaction Documents. The Company has no Subsidiaries. “Subsidiaries” means any Person in which the Company,
directly or indirectly, (I) owns any of the outstanding capital stock or holds any equity or similar interest of such Person or
(II) controls or operates all or any part of the business, operations or administration of such Person, and each of the foregoing,
is individually referred to herein as a “Subsidiary.” Additionally, to the extent that any Subsidiary is hereafter
created, and the context of the provision of this Agreement would ordinarily include a Subsidiary, then the term “Company”
will be deemed to include such Subsidiary.

 

(b)          Authorization;
Enforcement; Validity. The Company has the requisite power and authority to enter into and perform its obligations under this
Agreement and the other Transaction Documents and to issue the Securities in accordance with the terms hereof and thereof. The
execution and delivery of this Agreement and the other Transaction Documents by the Company, and the consummation by the Company
of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Notes and the reservation
for issuance and issuance of the Conversion Shares issuable upon conversion of the Notes) have been duly authorized by the Company’s
board of directors or other governing body, as applicable, and (other than the filing with the SEC of one or more Registration
Statements (as defined in the Registration Rights Agreement) in accordance with the requirements of the Registration Rights Agreement,
a Form D with the SEC and any other filings as may be required by any state securities agencies) no further filing, consent or
authorization is required by the Company, its respective boards of directors or the stockholders or other governing body. This
Agreement has been, and the other Transaction Documents will be prior to the Closing, duly executed and delivered by the Company,
and each constitutes the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with
its respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors’
rights and remedies and except as rights to indemnification and to contribution may be limited by federal or state securities law.
“Transaction Documents” means, collectively, this Agreement, the Notes, the Security Documents, the Registration
Rights Agreement, the Irrevocable Transfer Agent Instructions (as defined in the Registration Rights Agreement and each of the
other agreements and instruments entered into or delivered by any of the parties hereto in connection with the consummation of
the transactions contemplated hereby and thereby, as may be amended from time to time.

 

    	5

    	 

    

  

(c)          Issuance
of Conversion Shares. The Conversion Shares, when issued in accordance with the terms of the Notes, will be validly issued,
fully paid and non-assessable and free from all preemptive or similar rights, taxes, liens, charges and other encumbrances with
respect to the issue thereof under the terms thereof, with the holders being entitled to all rights accorded to a holder of Common
Stock. The Company shall have reserved from its duly authorized capital stock not less than one hundred ten percent (110%) of the
maximum number of Conversion Shares issuable upon conversion of the Notes in accordance with their terms. Subject to the accuracy
of the representations and warranties of the Buyers in this Agreement, the offer and issuance by the Company of the Securities
is exempt from registration under the 1933 Act.

 

(d)          No
Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the
Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Notes, the Conversion
Shares upon conversion of the Notes, the reservation for issuance of the Conversion Shares and the creation of the security interests
represented by the Security Documents) will not (i) result in a violation of the Certificate of Incorporation (as defined below)
(including, without limitation, any certificate of designation contained therein) or other organizational documents of the Company,
any capital stock of the Company or Bylaws (as defined below) of the Company, (ii) conflict with, or constitute a default (or an
event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture or instrument to which the Company is a party or (iii) result in a violation
of any law, rule, regulation, order, judgment or decree (including, without limitation, foreign, federal and state securities laws
and regulations) applicable to the Company or by which any property or asset of the Company is bound or affected except, in the
case of clause (ii) or (iii) above, to the extent such violations that could not reasonably be expected to have a Material Adverse
Effect.

 

(e)          Consents.
The Company is not required to obtain any consent from, authorization or order of, or make any filing or registration with (other
than the filing with the SEC of one or more Registration Statements in accordance with the requirements of the Registration Rights
Agreement, a Form D with the SEC and any other filings as may be required by any state securities agencies), any court, governmental
agency or any regulatory or self-regulatory agency or any other Person in order for it to execute, deliver or perform any of its
respective obligations under, or contemplated by, the Transaction Documents, in each case, in accordance with the terms hereof
or thereof. All consents, authorizations, orders, filings and registrations which the Company is required to obtain at or prior
to the Closing have been or will be obtained or made on or prior to the Closing Date, and the Company is not aware of any facts
or circumstances which might prevent the Company from obtaining or effecting any of the registration, application or filings contemplated
by the Transaction Documents.

 

    	6

    	 

    

  

(f)          Acknowledgment
Regarding Buyer’s Purchase of Securities. The Company acknowledges and agrees that each Buyer is acting solely in the
capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby
and thereby and that no Buyer is (i) an officer or director of the Company, (ii) an “affiliate” (as defined in Rule
144) of the Company or (iii) to its knowledge, a “beneficial owner” of more than ten percent (10%) of the shares of
Common Stock (as defined for purposes of Rule 13d-3 of the Securities and Exchange Act of 1934 Act, as amended (“1934
Act”)). The Company further acknowledges that no Buyer is acting as a financial advisor or fiduciary of the Company (or
in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby, and any
advice given by a Buyer or any of its representatives or agents in connection with the Transaction Documents and the transactions
contemplated hereby and thereby is merely incidental to such Buyer’s purchase of the Securities. The Company further represents
to each Buyer that the Company’s decision to enter into the Transaction Documents to which it is a party has been based solely
on the independent evaluation by the Company and its respective representatives.

 

(g)          No
General Solicitation; Placement Agent’s Fees. Neither the Company nor any Person acting on its behalf, has engaged in
any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale
of the Securities. The Company shall be responsible for the payment of any Placement Agent’s fees, financial advisory fees,
or brokers’ commissions (other than for Persons engaged by any Buyer or its investment advisor) relating to or arising out
of the transactions contemplated hereby. Other than the Placement Agent, to which a cash fee of 10% of the gross proceeds and a
warrant equal to 10% of the Conversion Shares, the Company has not engaged any placement agent or other broker or dealer in connection
with the offer or sale of the Securities.

 

(h)          No
Integrated Offering. None of the Company or, to its knowledge, any of its affiliates, nor any Person acting on its behalf has,
directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances
that would require registration of the issuance of any of the Securities under the 1933 Act, whether through integration with prior
offerings or otherwise, or cause this offering of the Securities to require approval of stockholders of the Company (other than
any required approval of holders of a majority of the outstanding common stock of the Company received before the Closing) under
any applicable stockholder approval provisions. None of the Company, nor its affiliates nor any Person acting on their behalf will
take any action or steps that would require registration of the issuance of any of the Securities under the 1933 Act or cause the
offering of any of the Securities to be integrated with other offerings of securities of the Company.

 

(i)          Dilutive
Effect. The Company understands and acknowledges that the number of Conversion Shares may increase in certain circumstances.
The Company further acknowledges that its obligation to issue the Conversion Shares upon conversion of the Notes in accordance
with this Agreement and the Notes is absolute and unconditional, regardless of the dilutive effect that such issuance may have
on the ownership interests of other stockholders of the Company.

 

(j)          Application
of Takeover Protections; Rights Agreement. The Company and its board of directors have taken all necessary action, if any,
in order to render inapplicable any control share acquisition, interested stockholder, business combination, poison pill (including,
without limitation, any distribution under a rights agreement) or other similar anti-takeover provision under the Certificate of
Incorporation, Bylaws or other organizational documents which is or could become applicable to any Buyer as a result of the consummation
of the transactions contemplated by this Agreement, including, without limitation, the Company’s issuance of the Securities
and any Buyer’s ownership of the Securities. The Company and its board of directors have taken all necessary action, if any,
in order to render inapplicable any stockholder rights plan or similar arrangement relating to accumulations of beneficial ownership
of shares of Common Stock or a change in control of the Company.

 

    	7

    	 

    

  

(k)          Placement
Documents; Financial Statements. The Private Placement Memorandum provided to the Buyers in connection with the sale of the
Notes, at the time of the date thereon, as it may be amended from time to time, did not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading. As of their respective dates, the financial statements of
the Company included in the private placement memorandum are unaudited and were not prepared in accordance with generally accepted
accounting principles, but fairly represented the financial position and results of the Company as of at and for the periods ended
on the dates of such financial statements. No other information provided by or on behalf of the Company to any of the Buyers taken
together with such Private Placement Memorandum contains any untrue statement of a material fact or omits to state any material
fact necessary in order to make the statements therein not misleading, in the light of the circumstance under which they are or
were made.

 

(l)          Absence
of Certain Changes. Since the date of the Company’s most recent financial statements contained in the Private Placement
Memorandum provided to the Buyers in connection with the sale of the Notes, there has been no material adverse change and no material
adverse development in the business, assets, liabilities, properties, operations (including results thereof), condition (financial
or otherwise) or prospects of the Company. Since the date of the Company’s most recent financial statements contained in
in the Private Placement Memorandum provided to the Buyer in connection with the sale of the Notes, the Company has not (i) declared
or paid any dividends (whether by cash, property or securities), (ii) sold any assets, individually or in the aggregate, outside
of the ordinary course of business or (iii) made any capital expenditures, individually or in the aggregate, outside of the ordinary
course of business. The Company has not taken any steps to seek protection pursuant to any law or statute relating to bankruptcy,
insolvency, reorganization, receivership, liquidation or winding up, nor does the Company have any knowledge or reason to believe
that any of their respective creditors intend to initiate involuntary bankruptcy proceedings or any actual knowledge of any fact
which would reasonably lead a creditor to do so. The Company is not as of the date hereof, and after giving effect to the transactions
contemplated hereby to occur at the Closing, will not be Insolvent (as defined below). “Insolvent” means (i)
the present fair saleable value of the Company’s assets is less than the amount required to pay the Company’s total
Indebtedness (as defined below), (ii) the Company is unable to pay its debts and liabilities, subordinated, contingent or otherwise,
as such debts and liabilities become absolute and matured or (iii) the Company intends to incur or believe that it will incur debts
that would be beyond its ability to pay as such debts mature.

 

(m)          No
Undisclosed Events, Liabilities, Developments or Circumstances. The Company has no knowledge of any event, liability, development
or circumstance that has occurred or exists, or that is reasonably expected to occur or exist with respect to the Company or any
of its business, properties, liabilities, operations (including results thereof) or condition (financial or otherwise), that (i)
would be required to be disclosed by the Company under applicable securities laws on a registration statement on Form S-1 filed
with the SEC relating to an issuance and sale by the Company of its Common Stock and which has not been publicly announced or disclosed
to the Buyers, (ii) could have a material adverse effect on any Buyer’s investment hereunder or (iii) could have a Material
Adverse Effect.

 

    	8

    	 

    

  

(n)          Conduct
of Business; Regulatory Permits. The Company is not in violation of any term of or in default under its Certificate of Incorporation
or Bylaws. The Company is not in violation of any judgment, decree or order or any statute, ordinance, rule or regulation applicable
to the Company, and the Company will not conduct its business in violation of any of the foregoing, except in all cases for possible
violations which could not, individually or in the aggregate, have a Material Adverse Effect. Except as set forth on Schedule
3(n) attached to the Disclosure Letter, the Company possess all certificates, authorizations and permits issued by the appropriate
regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such certificates,
authorizations or permits would not have, individually or in the aggregate, a Material Adverse Effect, and the Company has not
received any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit.

 

(o)          Foreign
Corrupt Practices. The Company and none of its directors, officers, agents, employees or other Persons acting on behalf of
the Company has, in the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution,
gift, entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment
to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision
of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment,
kickback or other unlawful payment to any foreign or domestic government official or employee.

 

(p)          Sarbanes-Oxley
Act. The Company is in compliance with all applicable requirements of the Sarbanes-Oxley Act of 2002 and all applicable rules
and regulations promulgated by the SEC thereunder.

 

(q)          Transactions
With Affiliates. Except as set forth on Schedule 3(q) attached to the Disclosure Letter and in the Private Placement
Memorandum provided to the Buyers in connection with the sale of the Notes, none of the officers, directors, employees or affiliates
of the Company is presently a party to any transaction with the Company (other than for ordinary course services as employees,
officers or directors and immaterial transactions), including any contract, agreement or other arrangement providing for the furnishing
of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from
any such officer, director, employee or affiliate or, to the knowledge of the Company, any corporation, partnership, trust or other
Person in which any such officer, director, employee or affiliate has a substantial interest or is an employee, officer, director,
trustee or partner.

 

    	9

    	 

    

  

(r)          Equity
Capitalization. As of the date hereof, the authorized capital stock of the Company consists solely of 50,000,000 shares of
Common Stock, of which, 4,800,000 are issued and outstanding and no shares are reserved for issuance pursuant to Convertible Securities
(as defined below) (other than the Notes), except as set forth on Schedule 3(r) attached to the Disclosure Letter. No approval
of the shareholders is required for the issuance of the Notes or the Conversion Shares or any of the Convertible Securities. No
shares of Common Stock are held in treasury. All of such outstanding shares are duly authorized and have been, or upon issuance
will be, validly issued and are fully paid and non-assessable. 4,272,000 shares of the Company’s issued and outstanding Common
Stock on the date hereof are owned by Persons who are “affiliates” (as defined in Rule 405 of the 1933 Act and calculated
based on the assumption that only officers, directors and holders of at least 10% of the Company’s issued and outstanding
Common Stock are “affiliates” without conceding that any such Persons are “affiliates” for purposes of
federal securities laws) of the Company. To the Company’s knowledge, no Person owns 10% or more of the Company’s issued
and outstanding shares of Common Stock (calculated based on the assumption that all Convertible Securities, whether or not presently
exercisable or convertible, have been fully exercised or converted (as the case may be) taking account of any limitations on exercise
or conversion (including “blockers”) contained therein without conceding in the private placement documentation that
such identified Person is a 10% stockholder for purposes of federal securities laws). Except as set forth on Schedule 3(r)
attached to the Disclosure Letter, (i) none of the Company’s capital stock is subject to preemptive rights or any other similar
rights or any liens or encumbrances suffered or permitted by the Company; (ii) there are no outstanding options, warrants, scrip,
rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into,
or exercisable or exchangeable for, any capital stock of the Company, or contracts, commitments, understandings or arrangements
by which the Company is or may become bound to issue additional capital stock of the Company or options, warrants, scrip, rights
to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable
or exchangeable for, any capital stock of the Company; (iii) there are no outstanding debt securities, notes, credit agreements,
credit facilities or other agreements, documents or instruments evidencing Indebtedness of the Company or by which the Company
is or may become bound; (iv) there are no financing statements securing obligations in any amounts filed in connection with the
Company; (v) there are no agreements or arrangements under which the Company is obligated to register the sale of any of their
securities under the 1933 Act (except pursuant to the Registration Rights Agreement and a warrant issued to the Placement Agent);
(vi) there are no outstanding securities or instruments of the Company by which the Company is or may become bound to redeem a
security of the Company; (vii) there are no securities or instruments containing anti-dilution or similar provisions that will
be triggered by the issuance of the Securities; and (viii) the Company has not issued any stock appreciation rights or “phantom
stock” plans or agreements or any similar plan or agreement. The Company has furnished to the Buyers true, correct and complete
copies of the Company’s Certificate of Incorporation, as amended and as in effect on the date hereof (the “Certificate
of Incorporation”), and the Company’s bylaws, as amended and as in effect on the date hereof (the “Bylaws”),
and the terms of all securities convertible into, or exercisable or exchangeable for, shares of Common Stock and the material rights
of the holders thereof in respect thereto. “Convertible Securities” means preferred stock, options, warrants
or other securities directly or indirectly convertible into, exchangeable for or exercisable for Common Stock of the Company.

 

    	10

    	 

    

  

(s)          Indebtedness
and Other Contracts. The Company, except as disclosed on Schedule 3(s) attached to the Disclosure Letter, (i) has no
outstanding Indebtedness (as defined below), (ii) is a party to any contract, agreement or instrument, the violation of which,
or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably be expected to result
in a Material Adverse Effect, (iii) is in violation of any term of, or in default under, any contract, agreement or instrument
relating to any Indebtedness, except where such violations and defaults would not result, individually or in the aggregate, in
a Material Adverse Effect, or (iv) is a party to any contract, agreement or instrument relating to any Indebtedness, the performance
of which, in the judgment of the Company’s officers, has or is expected to have a Material Adverse Effect. “Indebtedness”
of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed
as the deferred purchase price of property or services (including, without limitation, “capital leases” in accordance
with generally accepted accounting principles) (other than trade payables entered into in the ordinary course of business), (C)
all reimbursement or payment obligations with respect to letters of credit, surety bonds and other similar instruments, (D) all
obligations evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred in connection
with the acquisition of property, assets or businesses, (E) all indebtedness created or arising under any conditional sale or other
title retention agreement, or incurred as financing, in either case with respect to any property or assets acquired with the proceeds
of such indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event of default are
limited to repossession or sale of such property), (F) all monetary obligations under any leasing or similar arrangement which,
in connection with generally accepted accounting principles, consistently applied for the periods covered thereby, is classified
as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above secured by (or for which the holder of such
Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage, lien, pledge, charge, security interest
or other encumbrance upon or in any property or assets (including accounts and contract rights) owned by any Person, even though
the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all
Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G)
above. “Contingent Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise,
of that Person with respect to any indebtedness, lease, dividend or other obligation of another Person if the primary purpose or
intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability
that such liability will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders
of such liability will be protected (in whole or in part) against loss with respect thereto. “Person” means
an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.

 

(t)          Absence
of Litigation. Except as set forth on Schedule 3(t) attached to the Disclosure Letter, there is no action, suit, proceeding,
inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending
or, to the knowledge of the Company, threatened against or affecting the Company, the Common Stock or any of the Company’s
officers or directors which is outside of the ordinary course of business or individually or in the aggregate material to the Company.
There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the SEC or
other United States governmental agency involving the Company or any current or former director or officer of the Company.

 

    	11

    	 

    

  

(u)          Insurance.
Except as set forth in Schedule 3(u) attached to the Disclosure Letter, the Company is insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as management of the Company believes to be prudent
and customary in the businesses in which the Company is engaged. The Company has not been refused any insurance coverage sought
or applied for, and the Company has no any reason to believe that it will be unable to renew its existing insurance coverage as
and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
at a cost that would not have a Material Adverse Effect.

 

(v)         Employee
Relations. The Company is not a party to any collective bargaining agreement or employs any member of a union. The Company
believes that its relations with their respective employees are good. No executive officer (as defined in Rule 501(f) promulgated
under the 1933 Act) or other key employee of the Company has notified the Company that such officer intends to leave the Company
or otherwise terminate such officer’s employment with the Company. To the Company’s knowledge, no executive officer
or other key employee of the Company is, or is now expected to be, in violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement, non-competition agreement, or any other contract or agreement
or any restrictive covenant, and the continued employment of each such executive officer or other key employee (as the case may
be) does not subject the Company to any liability with respect to any of the foregoing matters. The Company is in compliance with
all federal, state, local and foreign laws and regulations respecting labor, employment and employment practices and benefits,
terms and conditions of employment and wages and hours, except where failure to be in compliance would not, either individually
or in the aggregate, reasonably be expected to result in a Material Adverse Effect.

 

(w)          Title.
The Company has good and marketable title to all personal property owned by it which is material to the business of the Company,
in each case, free and clear of all liens, encumbrances and defects except such as do not materially affect the value of such property
and do not interfere with the use made and proposed to be made of such property by the Company.

 

(x)          Intellectual
Property Rights. To the Company’s knowledge, the Company owns or possesses adequate rights or licenses to use all trademarks,
trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, original works, inventions,
licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications and
registrations therefor (“Intellectual Property Rights”) necessary to conduct is business as now conducted and
as presently proposed to be conducted. None of the Company’s Intellectual Property Rights have expired, terminated or been
abandoned, or are expected to expire, terminate or be abandoned, within three years from the date of this Agreement. The Company
has no knowledge of any infringement by the Company of Intellectual Property Rights of others. There is no claim, action or proceeding
being made or brought, or to the knowledge of the Company, being threatened, against the Company regarding their Intellectual Property
Rights. The Company is not aware of any facts or circumstances which might give rise to any of the foregoing infringements or claims,
actions or proceedings. The Company has taken reasonable security measures to protect the secrecy, confidentiality and value of
all of its Intellectual Property Rights.

 

    	12

    	 

    

  

(y)          Environmental
Laws. The Company (i) is in compliance with all Environmental Laws (as defined below), (ii) except as set forth on Schedule
3(y) attached to the Disclosure Letter, has received all permits, licenses or other approvals required of them under applicable
Environmental Laws to conduct its business, and (iii) is in compliance with all terms and conditions of any such permit, license
or approval where, in each of the foregoing clauses (i), (ii) and (iii), the failure to so comply could be reasonably expected
to have, individually or in the aggregate, a Material Adverse Effect. “Environmental Laws” means all federal,
state, local or foreign laws relating to pollution or protection of human health or the environment (including, without limitation,
ambient air, surface water, groundwater, land surface or subsurface strata), including, without limitation, laws relating to emissions,
discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes
(collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes,
decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations
issued, entered, promulgated or approved thereunder.

 

(z)          Tax
Status. The Company (i) has timely made or filed all foreign, federal and state income and all other tax returns, reports and
declarations required by any jurisdiction to which it is subject, (ii) has timely paid all taxes and other governmental assessments
and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those
being contested in good faith and (iii) has set aside on its books provision reasonably adequate for the payment of all taxes for
periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any
such claim. The Company is not operated in such a manner as to qualify as a passive foreign investment company, as defined in Section
1297 of the U.S. Internal Revenue Code of 1986, as amended.

 

(aa)         Internal
Accounting and Disclosure Controls. Except as set forth on Schedule 3(aa) attached to the Disclosure Letter, the Company
maintains internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the 1934 Act) that is effective
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes, including that (i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements to maintain asset and liability accountability,
(iii) access to assets or incurrence of liabilities is permitted only in accordance with management’s general or specific
authorization, and (iv) the recorded accountability for assets and liabilities is compared with the existing assets and liabilities
at reasonable intervals and appropriate action is taken with respect to any difference. The Company has not received any notice
or correspondence from any accountant or other Person relating to any potential material weakness or significant deficiency in
any part of the internal controls over financial reporting of the Company.

 

(bb)         Off
Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship involving the Company in respect of
an off-balance sheet entity that would be required to be disclosed by the Company in a 1934 Act filing or that otherwise could
be reasonably likely to have a Material Adverse Effect.

 

    	13

    	 

    

  

(cc)       Investment
Company Status. The Company is not, and upon consummation of the sale of the Securities will not be, an “investment company,”
or, to the knowledge of the Company, an affiliate of an “investment company,” a company controlled by an “investment
company” or an “affiliated person” of, or “promoter” or “principal underwriter” for,
an “investment company” as such terms are defined in the Investment Company Act of 1940, as amended.

 

(dd)       U.S.
Real Property Holding Corporation. The Company is not, and has never been a U.S. real property holding corporation within the
meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon any Buyer’s
request.

 

(ee)       Transfer
Taxes. On the Closing Date, all stock transfer or other taxes (other than income or similar taxes) which are required to be
paid in connection with the issuance, sale and transfer of the Securities to be sold to each Buyer hereunder will be, or will have
been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will have been complied with.

 

(ff)        Bank
Holding Company Act. The Company is not subject to the Bank Holding Company Act of 1956, as amended (the “BHCA”)
and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). The Company
nor any of its affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any
class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any equity that is subject to
the BHCA and to regulation by the Federal Reserve. The Company nor any of its affiliates exercises a controlling influence over
the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

(gg)       Shell
Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i).

 

(hh)       Public
Utility Holding Act. The Company is not a “holding company,” or an “affiliate” of a “holding
company,” as such terms are defined in the Public Utility Holding Act of 2005.

 

(ii)         Federal
Power Act. The Company is not subject to regulation as a “public utility” under the Federal Power Act, as amended.

 

(jj)         No
Additional Agreements. The Company does not have any agreement or understanding with any Buyer with respect to the transactions
contemplated by the Transaction Documents other than as specified in the Transaction Documents.

 

    	14

    	 

    

  

(kk)       Real
Property. The Company holds good title to all real property, leases in real property, or other interests in real property stated
as owned or held by the Company (the “Real Property”). The Real Property is free and clear of all mortgages,
defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other encumbrances
(collectively “Encumbrances”) and is not subject to any rights of way, building use restrictions, exceptions,
variances, reservations, or limitations of any nature except for (i) liens for current taxes not yet due, and (ii) zoning laws
and other land use restrictions that do not impair the present or anticipated use of the property subject thereto. Any Real Property
held under lease by the Company is held under valid, subsisting and enforceable leases with such exceptions as are not material
and do not interfere with the use made and proposed to be made of such property and buildings by the Company.

 

(ll)         Fixtures
and Equipment. The Company has good title to, or a valid leasehold interest in, the tangible personal property, equipment,
improvements, fixtures, and other personal property and appurtenances that are used by the Company in connection with the conduct
of its business (the “Fixtures and Equipment”). The Fixtures and Equipment are structurally sound, are in good
operating condition and repair, are adequate for the uses to which they are being put, are not in need of maintenance or repairs
except for ordinary, routine maintenance and repairs and are sufficient for the conduct of the Company’s business in the
manner as conducted prior to the Closing. The Company owns all of its Fixtures and Equipment free and clear of all Encumbrances
except for (i) liens for current taxes not yet due, and (ii) zoning laws and other land use restrictions that do not impair the
present or anticipated use of the property subject thereto.

 

(mm)     Illegal
or Unauthorized Payments; Political Contributions. The Company nor, to the best of the Company’s knowledge (after reasonable
inquiry of its officers and directors), any of the officers, directors, employees, agents or other representatives of the Company
or any other business entity or enterprise with which the Company is or has been affiliated or associated, has, directly or indirectly,
made or authorized any payment, contribution or gift of money, property, or services, whether or not in contravention of applicable
law, (i) as a kickback or bribe to any Person or (ii) to any political organization, or the holder of or any aspirant to any elective
or appointive public office except for personal political contributions not involving the direct or indirect use of funds of the
Company.

 

(nn)       Money
Laundering. The Company is in compliance with, and has not previously violated, the USA Patriot Act of 2001 and all other applicable
U.S. and non-U.S. anti-money laundering laws and regulations, including, without limitation, the laws, regulations and Executive
Orders and sanctions programs administered by the U.S. Office of Foreign Assets Control, including, without limitation, (i) Executive
Order 13224 of September 23, 2001 entitled, “Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten
to Commit, or Support Terrorism” (66 Fed. Reg. 49079 (2001)); and (ii) any regulations contained in 31 CFR, Subtitle B, Chapter
V.

 

(oo)       Ranking
of Notes. No Indebtedness of the Company, at the Closing, will be senior to, or pari passu with, the Notes in right
of payment, whether with respect to payment or redemptions, interest, damages, upon liquidation or dissolution or otherwise.

 

    	15

    	 

    

  

(pp)         Disclosure.
The Company confirms that neither it nor any other Person acting on its behalf has provided any of the Buyers or their agents or
counsel with any information that constitutes or could reasonably be expected to constitute material, non-public information concerning
the Company, other than the existence of the transactions contemplated by this Agreement and the other Transaction Documents. The
Company understands and confirms that each of the Buyers will rely on the foregoing representations in effecting the transactions
consummated hereunder. All disclosure provided to the Buyers regarding the Company, its business and the transactions contemplated
hereby, including the Private Placement Memorandum, the Disclosure Letter and the schedules to this Agreement, furnished by or
on behalf of the Company does not contain any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The
Company acknowledges and agrees that no Buyer makes or has made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in Section 2.

 

		4.	COVENANTS.

 

(a)          Best
Efforts. Each Buyer shall use its best efforts to timely satisfy each of the conditions to be satisfied by it as provided in
Section 6 of this Agreement. The Company shall use its best efforts to timely satisfy each of the conditions to be satisfied by
it as provided in Section 7 of this Agreement.

 

(b)          Form
D and Blue Sky. The Company shall file a Form D with respect to the Securities as required under Regulation D and to provide
a copy thereof to each Buyer promptly after such filing. The Company shall, on or before the Closing Date, take such action as
the Company shall reasonably determine is necessary in order to obtain an exemption for, or to, qualify the Securities for sale
to the Buyers at the Closing pursuant to this Agreement under applicable securities or “Blue Sky” laws of the states
of the United States (or to obtain an exemption from such qualification), and shall provide evidence of any such action so taken
to the Buyers on or prior to the Closing Date. Without limiting any other obligation of the Company under this Agreement, the Company
shall timely make all filings and reports relating to the offer and sale of the Securities required in connection with the consummation
of the transactions consummated hereunder under all applicable securities laws (including, without limitation, all applicable federal
securities laws and all applicable “Blue Sky” laws), and the Company shall comply with all applicable federal, foreign,
state and local laws, statutes, rules, regulations and the like relating to the offering and sale of the Securities to the Buyers.

 

(c)          Reporting
Status. After the date the Company becomes subject to the periodic reporting requirements under Sections 13 or 15(d) of the
1934 Act, as amended from time to time, together with the regulations promulgated thereunder (a “Reporting Company”),
and until the date on which the Buyers shall have sold all of the Registrable Securities (such period, to end in any event, whether
or not such securities have been sold, not later than five years after such date, the “Reporting Period”), the
Company shall use commercially reasonable efforts to timely file all reports required to be filed with the SEC pursuant to the
1934 Act, and the Company shall not terminate its status as an issuer required to file reports under the 1934 Act even if the 1934
Act or the rules and regulations thereunder would no longer require or otherwise permit such termination unless such termination
is approved by the holders of a majority stockholders of the voting power of the Company, or unless no Buyer has demand registration
rights under the Registration Rights Agreement or unless no Buyer is a holder of record of Conversion Shares (collectively, the
“Termination Conditions”).

 

    	16

    	 

    

  

(d)          Use
of Proceeds. The Company shall use the proceeds from the sale of the Securities for general corporate purposes as set forth
in the Private Placement Memorandum. Without limiting the foregoing, except as expressly set forth on Schedule 4(d) attached
to the Disclosure Letter, none of such proceeds shall be used, directly or indirectly, (i) for the satisfaction of any debt of
the Company, (ii) for the redemption of any securities of the Company (other than the Securities) or (iii) with respect to any
litigation involving the Company (including, without limitation, any settlement thereof).

 

(e)          Financial
Information. The Company agrees to send the following to each Buyer during the Reporting Period (i) unless the following are
filed with the SEC through EDGAR and are available to the public through the EDGAR system, within one (1) Business Day after the
filing thereof with the SEC, a copy of its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, any Current Reports on
Form 8-K and any registration statements (other than on Form S-8) or amendments filed pursuant to the 1933 Act; and (ii) copies
of any notices and other information made available or given to the stockholders of the Company generally, contemporaneously with
the making available or giving thereof to the stockholders.

 

(f)          Listing.
In connection with the Company becoming a Reporting Company, the Company shall in connection with any proper demand for registration
of Registrable Securities under the Registration Rights Agreement (if the same has not previously occurred) promptly secure the
listing or designation for quotation (as the case may be) of all of the Registrable Securities upon each national securities exchange
and automated quotation system, if any, upon which the Common Stock is then listed or designated for quotation (as the case may
be) (subject to official notice of issuance) and shall thereafter maintain such listing or designation for quotation (as the case
may be) of all Registrable Securities from time to time issuable under the terms of the Transaction Documents on such national
securities exchange or automated quotation system unless one of the Termination Conditions has occurred. During any period that
the Common Stock is listed or designated, the Company shall use commercially reasonable efforts to maintain the Common Stock’s
listing or designation for quotation (as the case may be) on The New York Stock Exchange, the NYSE MKT, the Nasdaq Global Select
Market, the Nasdaq Global Market or the Nasdaq Capital Market (each, an “Eligible Market”). During the Reporting
Period, the Company shall use commercially reasonable efforts not to take any action which could be reasonably expected to prevent
a listing or result in the delisting or suspension of the Common Stock from an Eligible Market. The Company shall pay all fees
and expenses in connection with satisfying its obligations under this Section 4(f).

 

(g)          Fees.
The Company shall be responsible for the payment of any placement agent’s fees, financial advisory fees, or broker’s
commissions (other than for Persons engaged by any Buyer) relating to or arising out of the transactions contemplated hereby and
resulting from the retention by the Company of any placement agent, financial advisor or broker (including, without limitation,
any fees payable to the Placement Agent, who is the Company’s sole placement agent in connection with the transactions contemplated
by this Agreement). Except where Buyer has breached Section 2(k) hereof, the Company shall pay, and hold each Buyer harmless against,
any liability, loss or expense (including, without limitation, reasonable attorneys’ fees and out-of-pocket expenses) arising
in connection with any claim relating to any such payment. Except as otherwise set forth in the Transaction Documents, each party
to this Agreement shall bear its own expenses in connection with the sale of the Securities to the Buyers.

 

    	17

    	 

    

  

(h)          Pledge
of Securities. Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges and agrees that
the Securities may be pledged by a Buyer in connection with a bona fide margin agreement or other bona fide loan or financing arrangement
that is secured by the Securities. The pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities
hereunder, and no Buyer making a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise
make any delivery to the Company pursuant to this Agreement or any other Transaction Document. The Company hereby agrees to execute
and deliver such documentation as a holder of the Securities may reasonably request in connection with a pledge of the Securities
to such pledgee by a Buyer.

 

(i)          Reservation
of Shares. The Company shall take all action necessary to at all times have authorized, and reserved for the purpose of issuance,
no less than one hundred ten percent (110%) of the maximum number of Conversion Shares issuable upon conversion of the Notes.

 

(j)          Conduct
of Business. So long as any of the Securities are held by the Buyers and their successors in interest and assigns, the business
of the Company shall not be conducted in violation of any law, ordinance or regulation of any governmental entity, except where
such violations would not result, either individually or in the aggregate, in a Material Adverse Effect.

 

(k)          Subsequent
Placements. Except as set forth on Schedule 4(k) attached to the Disclosure Letter, so long as the Notes are outstanding,
the Company shall, without the prior written consent of the Required Buyers (as defined below), be prohibited from effecting or
entering into an agreement to effect any offering or placement of equity or equity linked securities or debt of the Company (“Subsequent
Placement”), other than (i) a firm commitment underwritten initial public offering through a registered broker-dealer
(an “IPO”), or (ii) with LVP’s prior written consent, a Subsequent Placement (or series of Subsequent
Placements) in which in the aggregate gross proceeds to the Company do not exceed $2 million.

 

(l)          Change
of Control. Prior to an IPO, the Company may not effect a Change of Control without the prior written consent of the Required
Buyers. “Change in Control” means (x) the acquisition of the Company by another entity by means of any transaction
(including, without limitation, any stock acquisition, reorganization, merger or consolidation) that contemplates an enterprise
value of the Company of less than $60 million, or (y) a sale of all or substantially all of the assets of the Company for an aggregate
purchase price of less than $60 million (including, for purposes of this section, the sale or exclusive license of intellectual
property rights which, in the aggregate, constitutes substantially all of the corporation’s material intellectual property
assets).

 

    	18

    	 

    

  

(m)          Variable
Rate Transaction. Notwithstanding anything in this Agreement to the contrary, until the later of none of the Notes being outstanding
or three years after the Company becomes a Reporting Company, the Company shall be prohibited from effecting or entering into any
Subsequent Placement involving a Variable Rate Transaction. “Variable Rate Transaction” means a transaction
in which the Company (i) issues or sells any Convertible Securities either (A) at a conversion, exercise or exchange rate or other
price that is based upon and/or varies with the trading prices of, or quotations for, the shares of Common Stock at any time after
the initial issuance of such Convertible Securities, or (B) with a conversion, exercise or exchange price that is subject to being
reset at some future date after the initial issuance of such Convertible Securities or upon the occurrence of specified or contingent
events directly or indirectly related to the business of the Company or the market for the Common Stock, other than pursuant to
a customary “weighted average” anti-dilution provision or (ii) enters into any agreement (including, without limitation,
an “equity line of credit” or an “at the market offering”) whereby the Company may sell securities at a
future determined price (other than standard and customary “preemptive” or “participation” rights). Each
Buyer shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in
addition to any right to collect damages.

 

(n)          Passive
Foreign Investment Company. For the period ending on the third year anniversary after the Company becomes a Reporting Company,
the Company shall conduct its business in such a manner as will ensure that the Company will not be deemed to constitute a passive
foreign investment company within the meaning of Section 1297 of the U.S. Internal Revenue Code of 1986, as amended.

 

(o)          Restriction
on Redemption and Cash Dividends. So long as any Notes are outstanding, the Company shall not, directly or indirectly, redeem,
or declare or pay any cash dividend or distribution on, any securities of the Company without the prior express written consent
of the Required Buyers.

 

(p)          Corporate
Existence. So long as any Notes are outstanding, the Company shall maintain its corporate existence and shall not sell, assign
or transfer all or substantially all of the Company’s assets.

 

(q)          Board
of Directors; Size. So long as any Notes are outstanding, the Company will, within ninety (90) days of the Effective Date,
have a board of directors consisting of five members, of which three will be independent directors who will be mutually acceptable
to the Company and Liquid Venture Partners, LLC, an affiliate of the Placement Agent (“LVP”). Subject to any
legal rights under Delaware law of the shareholders, the number of members who shall constitute the board of directors of the Company,
may be changed only with the approval of LVP, which approval may be withheld in its discretion and subject to reasonable conditions,
including the requirement of additional independent directors.

 

(r)          Intellectual
Property Strategy. Within three months of the Effective Date, the Company will adopt an intellectual property strategy reasonably
acceptable to LVP, and provide a detailed written statement of the strategy to the Buyers.

 

    	19

    	 

    

  

(s)          Incentive
Equity. The Company may adopt an incentive stock or equity award plan, the terms of which are reasonably acceptable to LVP,
which plan provides for awards of shares equal to no more than fifteen percent (15%) of the number of fully diluted shares of Common
Stock up to and including the date of the IPO and giving effect to the IPO and debt conversions triggered by the IPO. Any such
plan will not be amended to increase the number of shares subject thereto until two (2) years after the Company becomes a Reporting
Company or upon the approval of LVP.

 

(t)          Independent
Accountants. Within three months after the date of initial issuance of the Notes, the Company will engage independent certified
public accountants, which firm is actively registered with the PCAOB, to perform an audit of the financial statements that would
be necessary and sufficient to meet the filing requirements of a registration statement for the registration of securities of the
Company either for issuance by the Company or resale of the Conversion Shares, which audit will be completed no later than nine
(9) months after the date of the initial issuance of the Notes.

 

(u)          Lock
Up. In connection with any initial public offering, the Company will use its best efforts to obtain lock-up agreements from
all its officer, directors, and employees, from any direct or beneficial holders of five percent (5%) or more of the shares of
Common Stock of the Company, and Liquid Patent Consultants, LLC (“LPC”) or the Placement Agent and any
beneficial holders of shares of Common Stock who are affiliates of LPC or the Placement Agent in respect of shares of Common Stock
issued under any agreement for the provision of patent and intellectual property services and issuable or issued upon exercise
of any warrants issued in connection with the offering by the Company of the Notes (the “Financing Shares”)
(for clarity, the lock up for LPC and the Placement Agent and their affiliates will not apply to any other shares of Common Stock,
including any shares of Common Stock acquired in the public markets); the foregoing lock up to extend for a period of 12 months
after the effective date of the registration statement for such initial public offering; except that the lock up with respect to
the Financing Shares shall only extend for a period of 6 months after the effective date of such registration statement.

 

(v)         Investor
Market Stand-Off. In connection with the initial public offering of the Company’s Common Stock, if any, each Buyer hereby
agrees that, for one hundred eighty (180) days from the effective date of such registration (the “Restricted Period”),
it will not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of any shares of Common Stock or
any securities convertible into or exercisable or exchangeable for Common Stock, whether now owned or hereafter acquired or with
respect to which such Buyer has or hereafter acquires the power of disposition; or (ii) enter into any swap or other agreement,
arrangement or transaction that transfers to another, in whole or in part, directly or indirectly, any of the economic consequence
of ownership of any Common Stock or any securities convertible into or exercisable or exchangeable for any Common Stock, whether
any transaction described in clause (i) or (ii) is to be settled by delivery of Common Stock, other securities, in cash or otherwise,
without the prior written consent of the managing or lead underwriter of such offering; provided, however that, if
during the last seventeen (17) days of the Restricted Period the Company issues an earnings release or material news or a material
event relating to the Company occurs, or prior to the expiration of the Restricted Period the Company announces that it will release
earnings results during the sixteen (16) day period beginning on the last day of the restricted period, then, upon the request
of the managing or lead underwriter, to the extent required by any FINRA rules, the restrictions imposed by this Section 4(v) shall
continue to apply until the end of the third (3rd) trading day following the expiration of the fifteen (15) day period
beginning on the issuance of the earnings release or the occurrence of the material news or material event. In no event will the
Restricted Period extend beyond two hundred sixteen (216) days after the effective date of the registration statement. In order
to enforce the restrictions agreed to by Buyer in this Section 4(v), the Company may impose stop-transfer instructions with respect
to any security acquired under or subject to this Agreement until the end of the Restricted Period. The Company’s underwriters
shall be third-party beneficiaries of the restrictions set forth in this Section 4(v).

 

    	20

    	 

    

  

(w)          IPO
Commitment. The Company shall use its best efforts to, no later than nine (9) months after the Effective Date, file with the
SEC a registration statement on Form S-1 (or any successor from thereto) to register and sell Common Stock in an IPO.

 

		5.	REGISTER; TRANSFER AGENT INSTRUCTIONS; LEGEND.

 

(a)          Register.
The Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may designate
by notice to each holder of Securities), a register for the Notes and, if issued, the Conversion Shares in which the Company shall
record the name and address of the Person in whose name the Notes and/or Conversion Shares have been issued (including the name
and address of each transferee), the principal amount of the Notes or aggregate number of Conversion Shares held by such Person,
and any tax related information required to be maintained. The Company shall keep the register open and available at all times
during business hours for inspection of any Buyer or its legal representatives.

 

(b)          Transfer
Agent Instructions. If a Buyer effects a sale, assignment or transfer of the Conversion Shares, the Company shall permit the
transfer and shall promptly instruct its transfer agent to issue one or more certificates or, if the Conversion Shares are eligible
for legend removal under Section 5(d), credit shares to the applicable balance accounts at the Depository Trust Company (“DTC”)
in such name and in such denominations as specified by such Buyer to effect such sale, transfer or assignment. In the event that
such sale, assignment or transfer involves Conversion Shares sold, assigned or transferred pursuant to an effective registration
statement or in compliance with Rule 144, the transfer agent shall issue such shares to such Buyer, assignee or transferee (as
the case may be) without any restrictive legend in accordance with Section 5(d) below. The Company acknowledges that a breach by
it of its obligations under this Section 5(b) will cause irreparable harm to each Buyer. Accordingly, the Company acknowledges
that the remedy at law for a breach of its obligations under this Section 5(b) will be inadequate and agrees, in the event of a
breach or threatened breach by the Company of the provisions of this Section 5(b), that each Buyer shall be entitled, in addition
to all other available remedies, to an order and/or injunction restraining any breach and requiring immediate issuance and transfer,
without the necessity of showing economic loss and without any bond or other security being required. The Company shall cause its
counsel to issue the legal opinion referred to in the Irrevocable Transfer Agent Instructions to the Company’s transfer agent
on each Effective Date (as defined and provided in the Registration Rights Agreement), provided that the applicable Buyer(s) or
its or their representatives and/or brokers have provided the documentation to counsel reasonably necessary or required for the
basis of such legal opinion. Any fees (with respect to the transfer agent, counsel to the Company or otherwise) associated with
the issuance of such opinion or the removal of any legends on any of the Securities shall be borne by the Company.

 

    	21

    	 

    

  

(c)          Legends.
Each Buyer understands that the Securities have been issued (or will be issued in the case of the Conversion Shares) pursuant to
an exemption from registration or qualification under the 1933 Act and applicable state securities laws, and except as set forth
below, the Securities shall bear any legend as required by the “Blue Sky” laws of any state and a restrictive legend
in substantially the following form (and a stop-transfer order may be placed against transfer of such stock certificates):

 

[NEITHER THE ISSUANCE AND SALE
OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN]/[THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE
STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER
(IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT
OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

(d)          Removal
of Legends. Certificates evidencing Securities shall not be required to contain the legend set forth in Section 5(c) above
or any other legend (i) while a registration statement (including a Registration Statement) covering the resale of such Securities
is effective under the 1933 Act, (ii) following any sale of such Securities pursuant to Rule 144 (assuming the transferor is not
an affiliate of the Company), (iii) if such Securities are eligible to be sold, assigned or transferred under Rule 144 (provided
that a Buyer provides the Company with reasonable assurances that such Securities are eligible and will remain for sale, assignment
or transfer under Rule 144 which shall not include an opinion of counsel), (iv) in connection with a sale, assignment or other
transfer (other than under Rule 144), provided that such Buyer provides the Company with an opinion of counsel to such Buyer, in
a generally acceptable form, to the effect that such sale, assignment or transfer of the Securities may be made without restrictive
legends and thereafter made without registration under the applicable requirements of the 1933 Act, or (v) if such legend is not
required under applicable requirements of the 1933 Act (including, without limitation, controlling judicial interpretations and
pronouncements issued by the SEC, provided that Buyer provides the Company with a reasonable description of the authority Buyer
is relying upon). If the Company is a Reporting Company and a legend is not required pursuant to the foregoing, the Company, at
its expense, shall no later than two (2) Business Days following the delivery by a Buyer to the Company or the transfer agent (with
notice to the Company) of a legended certificate representing such Securities (endorsed or with stock powers attached, signatures
guaranteed, and otherwise in form necessary to affect the reissuance and/or transfer, if applicable), together with any other deliveries
from such Buyer as may be required above in this Section 5(d), as directed by such Buyer, either: (A) provided that the Company’s
transfer agent is participating in the DTC Fast Automated Securities Transfer Program and such Securities are Conversion Shares,
credit the aggregate number of shares of Common Stock to which such Buyer shall be entitled to such Buyer’s or its designee’s
balance account with the DTC through its Deposit/Withdrawal at Custodian system or (B) if the Company’s transfer agent is
not participating in the DTC Fast Automated Securities Transfer Program, issue and dispatch for delivery (via reputable overnight
courier) to such Buyer, a certificate representing such Securities that is free from all restrictive and other legends, registered
in the name of such Buyer or its designee (the date by which such credit is so required to be made to the balance account of such
Buyer’s or such Buyer’s nominee with DTC or such certificate is required to be delivered to such Buyer pursuant to
the foregoing is referred to herein as the “Required Delivery Date”).

 

    	22

    	 

    

  

(e)          Failure
to Timely Deliver; Buy-In. If the Company is a Reporting Company and the Company improperly fails to (i) issue and dispatch
for delivery (or cause to be so dispatched) to a Buyer by the Required Delivery Date a certificate representing the Securities
so delivered to the Company by such Buyer that is free from all restrictive and other legends or (ii) credit the balance account
of such Buyer’s or such Buyer’s nominee with DTC for such number of Conversion Shares so delivered to the Company,
and if on or after the business day immediately following the Required Delivery Date such Buyer (or any other Person in respect,
or on behalf, of such Buyer) purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction
of a sale by such Buyer of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common
Stock equal to all or any portion of the number of shares of Common Stock, that such Buyer so anticipated receiving from the Company
without any restrictive legend, then, in addition to all other remedies available to such Buyer, the Company shall, within five
(5) Business Days after such Buyer’s request and in such Buyer’s sole discretion, either (x) pay cash to such Buyer
in an amount equal to such Buyer’s total purchase price (including brokerage commissions and other out-of-pocket expenses,
if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any)
(the “Buy-In Price”), at which point the Company’s obligation to so deliver such certificate or credit
such Buyer’s balance account shall terminate and such shares shall be cancelled, or (y) promptly honor its obligation to
so deliver to such Buyer a certificate or certificates or credit such Buyer’s DTC account representing such number of shares
of Common Stock that would have been so delivered if the Company timely complied with its obligations hereunder and pay cash to
such Buyer in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number of shares of Conversion
Shares that the Company was required to deliver to such Buyer by the Required Delivery Date multiplied by (B) the lowest closing
sale price of the Common Stock on any Business Day during the period commencing on the date of the delivery by such Buyer to the
Company of the applicable Conversion Shares and ending on the date of such delivery and payment under this clause (y).

 

		6.	CONDITIONS TO THE COMPANY’S OBLIGATION TO SELL.

 

(a)          The
obligation of the Company hereunder to issue and sell the Notes to each Buyer at the Closing is subject to the satisfaction, at
or before the Closing Date, of each of the following conditions, provided that these conditions are for the Company’s sole
benefit and may be waived by the Company at any time in its sole discretion by providing each Buyer with prior written notice thereof:

 

    	23

    	 

    

  

(i)          Such
Buyer shall have executed each of the other Transaction Documents to which it is a party and an Investor Questionnaire, and delivered
the same to the Company.

 

(ii)         Such
Buyer and each other Buyer shall have delivered to the Escrow Agent on behalf of the Company the Purchase Price for the Note being
purchased by such Buyer at the Closing by check in collected funds through the Escrow Agent or wire transfer of immediately available
funds pursuant to the wire instructions provided by the Company.

 

(iii)        The
representations and warranties of such Buyer shall be true and correct in all material respects as of the date when made and as
of the Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific
date, which shall be true and correct as of such date), and such Buyer shall have performed, satisfied and complied in all material
respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by
such Buyer at or prior to the Closing Date.

 

(iv)        The
Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the sale
of the Securities.

 

(v)         No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by the Transaction Documents.

 

(vi)        Since
the date of execution of this Agreement, no event or series of events shall have occurred that reasonably would have or result
in a Material Adverse Effect.

 

(vii)       That
Notes having an aggregate principal amount of at least $4,500,000 are purchased by the Buyers.

 

		7.	CONDITIONS TO EACH BUYER’S OBLIGATION TO PURCHASE.

 

(a)          The
obligation of each Buyer hereunder to purchase its Note at the Closing is subject to the satisfaction, at or before the Closing
Date, of each of the following conditions, provided that these conditions are for each Buyer’s sole benefit and may be waived
by such Buyer at any time in its sole discretion by providing the Company with prior written notice thereof:

 

    	24

    	 

    

 

 (i)          The
Company shall have duly executed and delivered to such Buyer each of the Transaction Documents to which it is a party and the
Company shall have duly executed and delivered to such Buyer a Note (in such original principal amount as is set forth across
from such Buyer’s name in column (2) of the Schedule of Buyers) being purchased by such Buyer at the Closing pursuant to
this Agreement.

 

(ii)         Buyer
shall have received an opinion of Greenberg Traurig, LLP, the Company’s counsel, dated the date of the issuance of the Note
to such Buyer, stating that the Company is duly incorporated, the Transaction Documents have been duly authorized, and that the
Conversion Shares, if and when issued will be duly authorized, fully paid and non-assessable, which opinion may be subject to such
assumptions and conditions are normally set forth in opinions of legal counsel in respect of such matters.

 

(iii)        The
Company shall have delivered to such Buyer a certificate evidencing the formation and good standing of the Company in its jurisdiction
of formation issued by the Secretary of State (or comparable office) of such jurisdiction of formation as of a date within ten
(10) days of the Closing Date.

 

(iv)        The
Company shall have delivered to such Buyer a certificate or other reasonably acceptable evidence evidencing the Company’s
qualification as a foreign corporation and good standing issued by the Secretary of State (or comparable office) of each jurisdiction
in which the Company conducts business and is required to so qualify, as of a date within ten (10) days of the Closing Date.

 

(v)         The
Company shall have delivered to such Buyer a certified copy of the Certificate of Incorporation as certified by the Secretary of
State of the Company’s jurisdiction of incorporation within ten (10) days of the Closing Date.

 

(vi)        The
Company shall have delivered to such Buyer a certificate, in the form acceptable to such Buyer, executed by the Secretary of the
Company dated as of the Closing Date, as to (i) the resolutions consistent with Section 3(b) as adopted by the Company’s
board of directors in a form reasonably acceptable to such Buyer, (ii) the Certificate of Incorporation of the Company and (iii)
the Bylaws of the Company as in effect at the Closing.

 

(vii)       Each
and every representation and warranty of the Company shall be true and correct as of the applicable Closing Date in all material
respects (except for representations and warranties that speak as of a specific date, which shall be true and correct as of such
date) and the Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and
conditions required to be performed, satisfied or complied with by the Company at or prior to the Closing Date. Such Buyer shall
have received a certificate, executed by the President of the Company, dated as of the Closing Date, to the foregoing effect and
as to such other matters as may be reasonably requested by such Buyer in the form reasonably acceptable to such Buyer.

 

    	25

    	 

    

  

(viii)      The
Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the sale
of the Securities.

 

(ix)         No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by the Transaction Documents.

 

(x)          Since
the date of execution of this Agreement, no event or series of events shall have occurred that reasonably would have or result
in a Material Adverse Effect.

 

(xi)         In
accordance with the terms of the Security Documents, the Company shall have delivered to such Buyer copies of appropriate financing
statements on Form UCC-1 to be duly filed in such office or offices and in the offices of the United States Patent and Trademark
Office as may be necessary or, in the opinion of the Buyers, desirable to perfect the first priority security interests purported
to be created by each Security Document.

 

(xii)        Within
two (2) Business Days prior to the Closing, the Company shall have delivered or caused to be delivered to each Buyer (i) true copies
of UCC search results in the Company’s jurisdiction of incorporation, listing all effective financing statements which name
as debtor the Company filed in the prior five years to perfect an interest in any assets thereof, together with copies of such
financing statements, none of which, except as otherwise agreed in writing by the Required Buyers, shall cover any of the Collateral
(as defined in the Security Documents) and the results of searches for any tax lien and judgment lien in the jurisdiction of the
Company’s principal place of business filed against such Person or its property, which results, except as otherwise agreed
to in writing by the Required Buyers shall not show any such Liens (as defined in the Security Documents); and (ii) a perfection
certificate, duly completed and executed by the Company, in form and substance reasonably satisfactory to the Required Buyers.

 

(xiii)       Since
the Effective Date, the Company shall not have amended, modified, waived compliance with or terminated, revoked or rescinded in
any manner or respect (and the Company shall not have taken any action, or permitted any action to be taken (whether through the
Company’s inaction or otherwise), that has a similar effect to any of the foregoing) any provision of any of material agreements
and all of such agreements shall be in full force and effect.

 

(xiv)      The
Company shall have delivered to such Buyer a letter dated as of the Closing Date, in a form reasonably acceptable to such Buyer,
executed by the Company (the “Disclosure Letter”).

 

    	26

    	 

    

  

(xv)       The
Company shall have delivered to such Buyer such other documents, instruments or certificates relating to the transactions contemplated
by this Agreement as such Buyer or its counsel may reasonably request.

 

(xvi)      That
Notes having an aggregate principal amount of at least $4,500,000 are purchased by the Buyers.

 

		8.	TERMINATION.

 

(a)          This
Agreement may be terminated prior to Closing:

 

(i)          by
written agreement of the Buyers and the Company; or

 

(ii)         by
either the Company or a Buyer (as to itself but no other Buyer) upon written notice to the other, if the Closing shall not have
taken place by 6:30 p.m. Eastern time on November 30, 2014; provided, that the right to terminate this Agreement under this Section
8(a)(ii) shall not be available to any party whose failure to comply with its obligations under this Agreement has been the cause
of or resulted in the failure of the Closing to occur on or before such time.

 

(b)          No
termination of this Agreement shall affect any obligation of the Company under this Agreement to reimburse such Buyer for the expenses
described in Section 4(g) above. Nothing contained in this Section 8 shall be deemed to release any party from any liability for
any breach by such party of the terms and provisions of this Agreement or the other Transaction Documents or to impair the right
of any party to compel specific performance by any other party of its obligations under this Agreement or the other Transaction
Documents.

 

		9.	MISCELLANEOUS.

 

(a)          Governing
Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this
Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict
of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the
laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees
not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is
improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees
that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be
deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall be deemed
or operate to preclude any Buyer from bringing suit or taking other legal action against the Company in any other jurisdiction
to collect on the Company’s obligations to such Buyer or to enforce a judgment or other court ruling in favor of such Buyer.
EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY. 

 

    	27

    	 

    

  

(b)          Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that
any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an
executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

(c)          Headings;
Gender. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation
of, this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine,
feminine, neuter, singular and plural forms thereof. The terms “including,” “includes,” “include”
and words of like import shall be construed broadly as if followed by the words “without limitation.” The terms “herein,”
“hereunder,” “hereof” and words of like import refer to this entire Agreement instead of just the provision
in which they are found.

 

(d)          Severability.
If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent
jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the
broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect
the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or
unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations
of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will
endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s),
the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s). Notwithstanding
anything to the contrary contained in this Agreement or any other Transaction Document (and without implication that the following
is required or applicable), it is the intention of the parties that in no event shall amounts and value paid by the Company, or
payable to or received by any of the Buyers, under the Transaction Documents (including without limitation, any amounts that would
be characterized as “interest” under applicable law) exceed amounts permitted under any applicable law. Accordingly,
if any obligation to pay, payment made to any Buyer, or collection by any Buyer pursuant the Transaction Documents is finally judicially
determined to be contrary to any such applicable law, such obligation to pay, payment or collection shall be deemed to have been
made by mutual mistake of such Buyer, and the Company and such amount shall be deemed to have been adjusted with retroactive effect
to the maximum amount or rate of interest, as the case may be, as would not be so prohibited by the applicable law. Such adjustment
shall be effected, to the extent necessary, by reducing or refunding, at the option of such Buyer, the amount of interest or any
other amounts which would constitute unlawful amounts required to be paid or actually paid to such Buyer under the Transaction
Documents. For greater certainty, to the extent that any interest, charges, fees, expenses or other amounts required to be paid
to or received by such Buyer under any of the Transaction Documents or related thereto are held to be within the meaning of “interest”
or another applicable term to otherwise be violative of applicable law, such amounts shall be pro-rated over the period of time
to which they relate.

 

    	28

    	 

    

  

(e)          Entire
Agreement; Amendments. This Agreement, the other Transaction Documents and the schedules and exhibits attached hereto and thereto
and the instruments referenced herein and therein supersede all other prior oral or written agreements between the Buyers, the
Company, their affiliates and Persons acting on their behalf solely with respect to the matters contained herein and therein, and
this Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced
herein and therein contain the entire understanding of the parties solely with respect to the matters covered herein and therein;
provided, however, nothing contained in this Agreement or any other Transaction Document shall (or shall be deemed to) (i) have
any effect on any agreements any Buyer has entered into with, or any instruments any Buyer has received from, the Company prior
to the date hereof with respect to any prior investment made by such Buyer in the Company or (ii) waive, alter, modify or amend
in any respect any obligations of the Company, or any rights of or benefits to any Buyer or any other Person, in any agreement
entered into prior to the date hereof between or among the Company and any Buyer, or any instruments any Buyer received from the
Company prior to the date hereof, and all such agreements and instruments shall continue in full force and effect. Except as specifically
set forth herein or therein, neither the Company nor any Buyer makes any representation, warranty, covenant or undertaking with
respect to such matters. For clarification purposes, the Recitals are part of this Agreement. No provision of this Agreement may
be amended other than by an instrument in writing signed by the Company and the Required Buyers, and any amendment to any provision
of this Agreement made in conformity with the provisions of this Section 9(e) shall be binding on all Buyers and holders of Securities,
as applicable, provided that no such amendment shall be effective to the extent that it (1) applies to less than all of the holders
of the Securities then outstanding or (2) imposes any obligation or liability on any Buyer without such Buyer’s prior written
consent (which may be granted or withheld in such Buyer’s sole discretion). No waiver shall be effective unless it is in
writing and signed by an authorized representative of the waiving party, provided that the Required Buyers may waive any provision
of this Agreement, and any waiver of any provision of this Agreement made in conformity with the provisions of this Section 9(e)
shall be binding on all Buyers and holders of Securities, as applicable, provided that no such waiver shall be effective to the
extent that it (1) applies to less than all of the holders of the Securities then outstanding (unless a party gives a waiver as
to itself only) or (2) imposes any obligation or liability on any Buyer without such Buyer’s prior written consent (which
may be granted or withheld in such Buyer’s sole discretion). No consideration shall be offered or paid to any Person to amend
or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration also
is offered to all of the parties to the Transaction Documents who are holders of Notes. The Company has not, directly or indirectly,
made any agreements with any Buyers relating to the terms or conditions of the transactions contemplated by the Transaction Documents
except as set forth in the Transaction Documents. Without limiting the foregoing, the Company confirms that, except as set forth
in this Agreement, no Buyer has made any commitment or promise or has any other obligation to provide any financing to the Company
or otherwise. As a material inducement for each Buyer to enter into this Agreement, the Company expressly acknowledges and agrees
that no due diligence or other investigation or inquiry conducted by a Buyer, any of its advisors or any of its representatives
shall affect such Buyer’s right to rely on, or shall modify or qualify in any manner or be an exception to any of, the Company’s
representations and warranties contained in this Agreement or any other Transaction Document. “Required Buyers”
means Buyers having Purchase Prices in the aggregate that are at least equal to fifty percent (50%) of the aggregate Purchase Prices
for all Buyers.

 

    	29

    	 

    

  

(f)          Notices.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must
be in writing and will be deemed to have been delivered: (i) upon receipt, if delivered personally; (ii) when sent, if sent by
facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party);
(iii) when sent, if sent by e-mail (provided that such sent e-mail is kept on file (whether electronically or otherwise) by the
sending party and the sending party does not receive an automatically generated message from the recipient’s e-mail server
that such e-mail could not be delivered to such recipient) and (iv) if sent by overnight courier service, one (1) Business Day
after deposit with an overnight courier service with next day delivery specified, in each case, properly addressed to the party
to receive the same. The addresses, facsimile numbers and e-mail addresses for such communications shall be:

 

If to the Company:

 

Aqua Metals, Inc.

501 23rd Avenue

Oakland, CA 94606

E-mail: Steve.Clarke@aqmetals.com

Attention: Dr. Stephen Clarke

 

with a copy (for informational
purposes only) to:

 

Greenberg Traurig, LLP

3161 Michelson Drive, Suite 1000

Irvine, CA 92612

Facsimile: (949) 732-6501

E-mail: DonahueD@gtlaw.com

Attention: Daniel K. Donahue, Esq.

 

If to a Buyer, to its address, facsimile
number or e-mail address set forth on such Buyer’s signature page hereto,

 

    	30

    	 

    

 

with a copy (for informational
purposes only) to:

 

Golenbock Eiseman Assor Bell & Peskoe LLP 

437 Madison Avenue, 40th Floor

New York, NY 10022

Facsimile:  (212) 754-0330

E-mail : ahudders@golenbock.com

              cvandemark@golenbock.com

Attention:  Andrew D. Hudders, Esq.

                   Carl Van Demark, Esq.

 

or to such other address, facsimile number
or e-mail address and/or to the attention of such other Person as the recipient party has specified by written notice given to
each other party five (5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient
of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s facsimile
machine containing the time, date and recipient facsimile number or (C) provided by an overnight courier service shall be rebuttable
evidence of personal service, receipt by facsimile or receipt from an overnight courier service in accordance with clause (i),
(ii) or (iv) above, respectively. A copy of the e-mail transmission containing the time, date and recipient e-mail address shall
be rebuttable evidence of receipt by e-mail in accordance with clause (iii) above.

 

(g)          Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and
assigns, including, as contemplated below, any assignee of any of the Securities. The Company shall not assign this Agreement or
any rights or obligations hereunder without the prior written consent of the Required Buyers; except in the event of a Change in
Control (as defined in the Notes) where the Company repays in full the outstanding Notes of each Buyer or offers each Buyer an
election to be repaid in full under such outstanding notes contingent only upon consummation of such Change in Control. A Buyer
may assign some or all of its rights hereunder in connection with any transfer of any of its Securities without the consent of
the Company, in which event such assignee shall be deemed to be a Buyer hereunder with respect to such assigned rights.

 

(h)          No
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, other than
the Indemnitees referred to in Section 9(k).

 

(i)          Survival.
The representations, warranties, agreements and covenants shall survive the Closing and shall expire on the conversion of the Notes
into Conversion Shares. Each Buyer shall be responsible only for its own representations, warranties, agreements and covenants
hereunder.

 

(j)          Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

    	31

    	 

    

  

(k)          Indemnification.
In consideration of each Buyer’s execution and delivery of the Transaction Documents and acquiring the Securities thereunder
and in addition to all of the Company’s other obligations under the Transaction Documents, the Company shall defend, protect,
indemnify and hold harmless each Buyer and each holder of any Securities and all of their stockholders, partners, members, officers,
directors, employees and direct or indirect investors and any of the foregoing Persons’ agents or other representatives (including,
without limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages,
and expenses in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification
hereunder is sought), and including reasonable attorneys’ fees and disbursements for one (1) counsel to all the Buyers (the
“Indemnified Liabilities”), incurred by any Indemnitee as a result of, or arising out of, or relating to (a)
any misrepresentation or breach of any representation or warranty made by the Company in any of the Transaction Documents, (b)
any breach of any covenant, agreement or obligation of the Company contained in any of the Transaction Documents or (c) any cause
of action, suit, proceeding or claim brought or made against such Indemnitee by a third party (including for these purposes a derivative
action brought on behalf of the Company) or which otherwise involves such Indemnitee that arises out of or results from (i) the
execution, delivery, performance or successful enforcement of any of the Transaction Documents, (ii) any transaction financed or
to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities, or (iii) the status
of such Buyer or holder of the Securities either as an investor in the Company pursuant to the transactions contemplated by the
Transaction Documents or as a party to this Agreement (including, without limitation, as a party in interest or otherwise in any
action or proceeding for injunctive or other equitable relief). To the extent that the foregoing undertaking by the Company may
be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the
Indemnified Liabilities which is permissible under applicable law. Except as otherwise set forth herein, the mechanics and procedures
with respect to the rights and obligations under this Section 9(k) shall be the same as those set forth in Section 6 of the Registration
Rights Agreement. No Indemnitee shall be entitled to indemnification under this Section 9(k) to the extent an Indemnified Liability
arises out of the gross negligence or willful misconduct of such Indemnitee. The Company shall not be obligated hereunder for any
settlement entered into by an Indemnitee without the Company’s prior written consent; provided, however, that the Company
shall not unreasonably withhold, delay or condition its consent.

 

(l)          Construction.
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and
no rules of strict construction will be applied against any party. No specific representation or warranty shall limit the generality
or applicability of a more general representation or warranty. Each and every reference to share prices, shares of Common Stock
and any other numbers in this Agreement that relate to the Common Stock shall be automatically adjusted for stock dividends, stock
splits, stock combinations and other similar transactions that occur with respect to the Common Stock after the date of this Agreement.

 

    	32

    	 

    

  

(m)          Remedies.
Each Person having any rights under any provision of this Agreement shall have all rights and remedies set forth in the Transaction
Documents and all rights and remedies which such holders have been granted at any time under any other agreement or contract and
all of the rights which such holders have under any law. Any Person having any rights under any provision of this Agreement shall
be entitled to enforce such rights specifically (without posting a bond or other security), to recover damages by reason of any
breach of any provision of this Agreement and to exercise all other rights granted by law. Furthermore, the Company recognizes
that in the event that it fails to perform, observe, or discharge any or all of its obligations under the Transaction Documents,
any remedy at law may prove to be inadequate relief to the Buyers. The Company therefore agrees that the Buyers shall be entitled
to seek specific performance and/or temporary, preliminary and permanent injunctive or other equitable relief from any court of
competent jurisdiction in any such case without the necessity of proving actual damages and without posting a bond or other security.

 

(n)          Withdrawal
Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction
Documents, whenever any Buyer exercises a right, election, demand or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein provided, then such Buyer may rescind or withdraw, in its sole
discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without
prejudice to its future actions and rights.

 

(o)          Payment
Set Aside; Currency. To the extent that the Company makes a payment or payments to any Buyer hereunder or pursuant to any of
the other Transaction Documents or any of the Buyers enforce or exercise their rights hereunder or thereunder, and such payment
or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent
or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company,
a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, foreign, state or federal
law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally
intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement
or setoff had not occurred. Unless otherwise expressly indicated, all dollar amounts referred to in this Agreement and the other
Transaction Documents are in United States Dollars (“U.S. Dollars”), and all amounts owing under this Agreement
and all other Transaction Documents shall be paid in U.S. Dollars. All amounts denominated in other currencies (if any) shall be
converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. “Exchange
Rate” means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Agreement,
the U.S. Dollar exchange rate as published in The Wall Street Journal on the relevant date of calculation.

 

    	33

    	 

    

  

(p)          Independent
Nature of Buyers’ Obligations and Rights. The obligations of each Buyer under the Transaction Documents are several and
not joint with the obligations of any other Buyer, and no Buyer shall be responsible in any way for the performance of the obligations
of any other Buyer under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action
taken by any Buyer pursuant hereto or thereto, shall be deemed to constitute the Buyers as, and the Company acknowledges that the
Buyers do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption
that the Buyers are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated
by the Transaction Documents or any matters, and the Company acknowledges that the Buyers are not acting in concert or as a group,
and the Company shall not assert any such claim, with respect to such obligations or the transactions contemplated by the Transaction
Documents. The decision of each Buyer to purchase Securities pursuant to the Transaction Documents has been made by such Buyer
independently of any other Buyer. Each Buyer acknowledges that no other Buyer has acted as agent for such Buyer in connection with
such Buyer making its investment hereunder and that no other Buyer will be acting as agent of such Buyer in connection with monitoring
such Buyer’s investment in the Securities or enforcing its rights under the Transaction Documents. The Company and each Buyer
confirms that each Buyer has independently participated with the Company in the negotiation of the transaction contemplated hereby
with the advice of its own counsel and advisors. Each Buyer shall be entitled to independently protect and enforce its rights,
including, without limitation, the rights arising out of this Agreement or out of any other Transaction Documents, and it shall
not be necessary for any other Buyer to be joined as an additional party in any proceeding for such purpose. The use of a single
agreement to effectuate the purchase and sale of the Securities contemplated hereby was solely in the control of the Company, not
the action or decision of any Buyer, and was done solely for the convenience of the Company and not because it was required or
requested to do so by any Buyer. It is expressly understood and agreed that each provision contained in this Agreement and in each
other Transaction Document is between the Company and a Buyer, solely, and not between the Company and the Buyers collectively
and not between and among the Buyers.

 

[Signature pages follow]

 

    	34

    	 

    

 

IN WITNESS WHEREOF,
Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first
written above. 

 

	 	COMPANY:
	 	 
	 	Aqua Metals, Inc.,
	 	a Delaware corporation
	 	 	 
	 	By:	/s/ Stephen R. Clarke
	 	 	Dr. Stephen R. Clarke
	 	 	President and Chief Executive Officer

  

    	 

    	 

    

 

IN WITNESS WHEREOF,
Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written
above.

	 	 
	BUYERS:	 
	 	 
	
        For Entity Investors

         

        Print Name: ________________________________

         

        Signature:__________________________________

         

        Name of Signatory: __________________________

         

        Title: _____________________________________

         

        Telephone No. ______________________________

         

        Facsimile Number: ___________________________

         

        E-mail Address: _____________________________

         

        Social Security # or Fed ID #___________________

         

        ___________________________________________

        Street Address

         

        ___________________________________________

        Street Address – 2nd line

         

        ___________________________________________

        City, State, Zip
	
        For Individual Investors:

         

        Print Name: _________________________________

         

        Signature:___________________________________

         

        Social Security # or Fed ID #:____________________

         

        If Joint Investment, 2nd investor
        should complete:

         

        Print Name:____________+______________________

         

        Signature:_____________________________________

         

        Social Security # or Fed ID #:_____________________

         

        Telephone No. ______________________________

         

        Facsimile No. _______________________________

         

        E-mail Address: _____________________________

         

        __________________________________________

        Street Address

         

        __________________________________________

        Street Address – 2nd line

         

        __________________________________________

        City, State, Zip
	 

 

[See Next Page for Buyer Addendum
Re Escrow]

 

    	 

    	 

    

 

BUYER ADDENDUM RE ESCROW

(this information is required )

 

By signing above the above signed Buyer
hereby certifies and confirms that: In the event that the Escrow Agent makes a disbursement to the above signed Buyer, which may
or may not occur, such Buyer hereby confirms that such disbursement is to be made by wire transfer using the following wire transfer
instructions. The Escrow Agent, the Company and the Placement Agent can rely on this confirmation and I will not revoke this confirmation
unless I confirm to the Company on this form replacement wire transfer instructions at least two Business Days before revoking
this confirmation. The Company may instruct the Escrow Agent to, or the Escrow Agent may on its own, withhold any such disbursement
until the Company is reasonably satisfied and the Escrow Agent is satisfied in its sole discretion with the instructions and procedures
for making such disbursement.

 

Bank Name: ______________________

 

Bank Address: ____________________

 

ABA Number: ____________________

 

Account Number: _________________

 

Account Name: ___________________

 

Reference: _______________________ 

 

    	 

    	 

    

 

EXHIBIT A

 

SCHEDULE OF BUYERS 

 

	(1)	(2)	(3)
	Buyer	Original Principal

Amount of Note	Purchase Price
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

    	Exhibit A-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}]]